<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Late Night Pyq:Pyt (Pathology-4) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}


    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Late Night PYQ
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">60</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 10465,
    "choices": [
      {
        "id": 41826,
        "text": "<p><span style=\"font-size:12.0pt;\">Serum ferritin levels</span></p>"
      },
      {
        "id": 41827,
        "text": "<p><span style=\"font-size:12.0pt;\">HbA2 levels</span></p>"
      },
      {
        "id": 41828,
        "text": "<p><span style=\"font-size:12.0pt;\">Serum folate levels</span></p>"
      },
      {
        "id": 41829,
        "text": "<p><span style=\"font-size:12.0pt;\">Serum homocysteine levels</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A female patient presented with fatigue. Routine complete blood count analysis showed hemoglobin of 9 g/dL, MCV 60fL, and RBC count of 5.2 million. A peripheral smear showed microcytic hypochromic anemia. Which of the following is the next best investigation for this patient? (NEET PG 2022)</span></p>",
    "unique_key": "Q4495419",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676657,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) HbA2 levels</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Question is testing applied knowledge. Mentzer\u2019s index needs to be calculated&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A peripheral blood smear with microcytic hypochromic cells and a Mentzer index of less than 13 indicates thalassemia. As a result, HbA2 levels (which are elevated in thalassemia) must be tested next.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Mentzer index, also known as the MCV/RBC count, can be used to distinguish thalassemia from iron-deficiency anemia (IDA). In both IDA and thalassemia, MCV (mean corpuscular volume) and MCH (mean corpuscular hemoglobin) are low. RBC count may be normal in thalassemia but decreased in IDA. A lower RBC count in IDA indicates a smaller denominator, resulting in a higher MCV/RBC ratio.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mentzer index is</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">More than 13 in iron-deficiency anemia</span></li><li><span style=\"font-size:12.0pt;\">Less than 13 in thalassemia</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Alpha- and beta-thalassemia are inherited disorders in which there is reduced production of alpha-globin or beta-globin chains, respectively. This leads to precipitation of the excess (unpaired) chains, interfering with red blood cell (RBC) production and survival.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinical features in thalassemia include anemia, jaundice, skeletal deformities including facial deformities, changes in body habits, growth impairment, and hepatosplenomegaly. Due to frequent blood transfusions, iron overload is also seen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Peripheral smear is likely to show microcytic hypochromic anemia with target cells, teardrop cells, and some coarse basophilic stippling in certain cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Serum ferritin levels</strong>: Relevant for diagnosing iron deficiency anemia but less specific for thalassemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Serum folate levels</strong>: Relevant for diagnosing macrocytic anemia due to folate deficiency, not typically useful for microcytic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Serum homocysteine levels</strong>: Elevated in cases of vitamin B12 or folate deficiency, related to macrocytic anemia, not microcytic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For a patient presenting with microcytic hypochromic anemia and an RBC count suggesting thalassemia (Mentzer index &lt; 13), the next best investigation is to measure HbA2 levels to confirm the diagnosis of beta-thalassemia.</span></p>",
    "correct_choice_id": 41827,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 21430,
    "choices": [
      {
        "id": 85684,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2, 3, 4</span></span></span></p>"
      },
      {
        "id": 85685,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2, 7, 9, 10</span></span></span></p>"
      },
      {
        "id": 85686,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">8, 9, 11</span></span></span></p>"
      },
      {
        "id": 85687,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3, 7, 9, 10</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following are vitamin K dependent factors requiring gamma carboxylation? (</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NEETPG 2023)</span></span></p>",
    "unique_key": "Q2144478",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676636,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) 2, 7, 9, 10</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin K is essential for the post-translational modification of certain proteins required for blood coagulation. This modification is gamma carboxylation, which allows these proteins to bind calcium ions and participate effectively in the coagulation cascade.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Vitamin K Dependent Factors:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Procoagulants:</span></strong><span style=\"font-size:12.0pt\"> Factors II (prothrombin), VII, IX, and X.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Anticoagulants:</span></strong><span style=\"font-size:12.0pt\"> Protein C and Protein S.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">These factors are synthesized in the liver and require gamma carboxylation of specific glutamic acid residues for their activity. Without this modification, they cannot bind calcium effectively, which is necessary for their role in coagulation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vitamin K dependent factors are procoagulants (factors 2,7,9,10) and anticoagulants (protein C and S). They require gamma carboxylation for their activity. </span></span></span></p>",
    "correct_choice_id": 85685,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 9840,
    "choices": [
      {
        "id": 39327,
        "text": "<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Small-cell lung cancer</span></span></span></p>"
      },
      {
        "id": 39328,
        "text": "<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CMV-associated organizing pneumonia</span></span></span></p>"
      },
      {
        "id": 39329,
        "text": "<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cryptococcal pneumonia</span></span></span></p>"
      },
      {
        "id": 39330,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tuberculosis</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old HIV-positive man presented with fever and breathlessness for 2 weeks. Imaging shows dense infiltration in the lower lobe and the lung biopsy showed the following finding. What is the diagnosis?</span></span> (AIIMS MAY 2018)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/973.jpg\" style=\"height:199px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q3996767",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676663,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>B) CMV-associated organizing pneumonia</strong></span></span></span></p>\r\n\r\n<p style=\"margin-right:4px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given image shows a cytomegalic pneumocyte containing characteristic intranuclear basophilic inclusion surrounded by a clear halo known <strong>as owl&#39;s eye appearance</strong>. Along with the given clinical scenario, it is suggestive of cytomegalovirus (<strong>CMV) pneumonia</strong>.</span></span></span></p>\r\n\r\n<p style=\"margin-right:4px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CMV is a -group herpesvirus. It causes the following conditions:</span></span></span></p>\r\n\r\n<p style=\"margin-right:4px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">I<strong>mmunocompetent</strong> individuals - asymptomatic or mononucleosis-like infection</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Neonates </strong>- devastating systemic infections</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">I<strong>mmunosuppressed</strong> individuals - serious, life-threatening, disseminated CMV infections of the lungs (pneumonitis) and gastrointestinal tract (colitis)</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:4px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:4px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Small-cell lung cancer</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This does not present with the characteristic owl&#39;s eye appearance seen in CMV infection.</span></span></span></p>\r\n\r\n<p style=\"margin-right:4px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Cryptococcal pneumonia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Cryptococcosis is a fungal infection that can affect the lungs but typically presents with encapsulated yeast forms, not the cytomegalic cells characteristic of CMV.</span></span></span></p>\r\n\r\n<p style=\"margin-right:4px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Tuberculosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: TB typically presents with granulomas and caseating necrosis rather than the cytomegalic changes seen in CMV pneumonia.</span></span></span></p>\r\n\r\n<p style=\"margin-right:4px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:4px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The presence of <strong>owl&#39;s eye intranuclear inclusions</strong> in pneumocytes on lung biopsy, especially in an immunocompromised patient, is strongly suggestive of <strong>CMV-associated organizing pneumonia</strong>.</span></span></span></p>\r\n\r\n<p style=\"margin-right:4px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbin and Cotran pathologic basis of disease 8<sup>th</sup> edition pg 639-640</span></strong></span></span></p>",
    "correct_choice_id": 39328,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "ImageBased"
    ]
  },
  {
    "id": 9937,
    "choices": [
      {
        "id": 39714,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ewing&#39;s sarcoma</span></span></span></p>"
      },
      {
        "id": 39715,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Embryonal rhabdomyosarcoma</span></span></span></p>"
      },
      {
        "id": 39716,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Leukemia</span></span></span></p>"
      },
      {
        "id": 39717,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Retinoblastoma</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 4-year-old child was brought to OPD with proptosis of left eye. On investigation, it was found to be a Desmin positive tumour. What can be the likely diagnosis? (AIIMS MAY 2021)</span></span></p>",
    "unique_key": "Q1638733",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676648,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;<strong>B) Embryonal rhabdomyosarcoma</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Given clinical scenario and tumor showing Desmin positive, points to a diagnosis of Embryonal Rhabdomyosarcoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Embryonal rhabdomyosarcoma&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">presents as a soft gray infiltrative mass. The tumor cells mimic skeletal muscle at various stages of differentiation and consist of sheets of both primitive round and spindled cells. Rhabdomyoblasts with straplike cytoplasm and visible cross-striations may be present.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sarcoma botryoides&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is a variant of embryonal rhabdomyosarcoma that develops in the walls of hollow viscera such as the urinary bladder and vagina.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture23.jpg\" style=\"height:127px; width:600px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Ewing&#39;s sarcoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Ewing&#39;s sarcoma is typically positive for CD99 and is more commonly found in bone or soft tissue, not usually associated with Desmin positivity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Leukemia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Leukemia cells are positive for CD45 (leukocyte common antigen) and are not associated with Desmin positivity or presenting as a soft tissue mass with proptosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Retinoblastoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Retinoblastoma is a malignant tumor of the retina, typically presenting with leukocoria (white pupillary reflex) and is associated with RB1 gene mutations. It is not associated with Desmin positivity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Embryonal rhabdomyosarcoma, a common pediatric soft tissue sarcoma, is typically Desmin-positive and can present with proptosis, particularly when it arises in the orbit.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and Cotran pathologic basis of disease 8<sup>th</sup> edition pg 2435-2437</span></strong></span></span></p>",
    "correct_choice_id": 39715,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 47559,
    "choices": [
      {
        "id": 189847,
        "text": "<p><span style=\"font-size:12.0pt;\">47 XXX</span></p>"
      },
      {
        "id": 189848,
        "text": "<p><span style=\"font-size:12.0pt;\">46 XX</span></p>"
      },
      {
        "id": 189849,
        "text": "<p><span style=\"font-size:12.0pt;\">45 XO</span></p>"
      },
      {
        "id": 189850,
        "text": "<p><span style=\"font-size:12.0pt;\">47 XXY</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 13-year-old girl was brought to the OPD with complaint of delayed puberty, primary amenorrhea, and secondary sexual development. On examination, there was webbed neck and widely spaced nipples. Which karyotype is associated with the given condition? (</span>FMGE Jan 2024)</p>",
    "unique_key": "Q9085669",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676643,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 45 XO</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation described in the question is characteristic of Turner syndrome, a genetic disorder caused by complete or partial absence of one X chromosome in females. The key features that suggest Turner syndrome in this patient are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Delayed puberty and primary amenorrhea: </strong>Due to the presence of streak gonads (non-functional ovaries) in Turner syndrome, patients often experience delayed puberty and primary amenorrhea (absence of menstrual periods).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Lack of secondary sexual development: </strong>The absence of functional ovaries leads to a lack of estrogen production, resulting in poor development of secondary sexual characteristics, such as breast development and pubic hair growth.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Webbed neck: </strong>A short, wide neck with excess skin folds (webbing) is a common physical feature in Turner syndrome.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Widely spaced nipples (shield chest): </strong>This is another characteristic physical finding in Turner syndrome, resulting from the altered body proportions.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-152825.png\" alt=\"\" width=\"300\" height=\"438\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The karyotype associated with classic Turner syndrome is 45,X (also written as 45,XO), indicating the presence of only one X chromosome instead of the normal two in females. This monosomy of the X chromosome is responsible for the clinical features observed in Turner syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 47, XXX (Triple X syndrome):</strong> This karyotype is associated with an extra X chromosome in females but does not typically present with the features described in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 46, XX:</strong> This is the normal female karyotype and does not explain the clinical presentation of the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 47, XXY (Klinefelter syndrome):</strong> This karyotype is associated with an extra X chromosome in males and presents with different clinical features, such as tall stature, gynecomastia, and hypogonadism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional information:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Patients with Turner syndrome are at increased risk of various complications, such as:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Congenital heart defects (e.g., coarctation of the aorta, bicuspid aortic valve)</span></li><li><span style=\"font-size:12.0pt;\">Metabolic syndrome (obesity, insulin resistance, dyslipidemia)</span></li><li><span style=\"font-size:12.0pt;\">Autoimmune disorders (e.g., Hashimoto's thyroiditis, celiac disease)</span></li><li><span style=\"font-size:12.0pt;\">Osteoporosis due to estrogen deficiency</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Turner syndrome, characterized by the 45,XO karyotype, should be suspected in a female patient presenting with delayed puberty, primary amenorrhea, lack of secondary sexual development, and characteristic physical features such as webbed neck and widely spaced nipples.</span></p>",
    "correct_choice_id": 189849,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE"
    ]
  },
  {
    "id": 50700,
    "choices": [
      {
        "id": 202339,
        "text": "<p><span style=\"font-size:12.0pt;\">Orthostatic hypotension</span></p>"
      },
      {
        "id": 202340,
        "text": "<p><span style=\"font-size:12.0pt;\">Tachycardia</span></p>"
      },
      {
        "id": 202341,
        "text": "<p><span style=\"font-size:12.0pt;\">Gastrointestinal disturbance</span></p>"
      },
      {
        "id": 202342,
        "text": "<p><span style=\"font-size:12.0pt;\">Tachyphylaxis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">All of the following are side effects of nitrates, EXCEPT: (NEET PG 2016)</span></p>",
    "unique_key": "Q6675800",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676618,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><strong>Correct Answer: C. Gastrointestinal disturbance</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>The adverse effects of nitrates are primarily related to their vasodilatory properties. These include fullness in head, throbbing headache, flushing, weakness, sweating, palpitation, dizziness and fainting. These symptoms occur due to postural hypotension and can be mitigated by lying down. Gastrointestinal disturbances are not characteristic side effects of nitrate therapy.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><ul><li><strong>Option A. Orthostatic hypotension&nbsp;</strong>- Postural (orthostatic) hypotension is a well-documented side effect of nitrates. Standing still and alcohol consumption can accentuate this effect due to enhanced peripheral pooling of blood.</li><li><strong>Option B. Tachycardia -</strong> With large doses of nitrates and significant drops in mean blood pressure, reflex sympathetic stimulation occurs, leading to tachycardia and increased cardiac contractility. This can paradoxically increase cardiac work and potentially precipitate angina.</li><li><strong>Option D. Tachyphylaxis -</strong> Tolerance (tachyphylaxis) to the hemodynamic and anti-ischemic effects of nitrates develops in a dose and duration-dependent manner when they are continuously present in the body. This tolerance wanes rapidly (within hours) when the body is free of the drug.</li></ul><p>&nbsp;</p><p><strong>Educational Objective:&nbsp;</strong></p><p>&nbsp;</p><p>Nitrates produce side effects primarily related to vasodilation and can lead to tolerance with continuous use, but gastrointestinal disturbances are not characteristic of this drug class.</p>",
    "correct_choice_id": 202341,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 14640,
    "choices": [
      {
        "id": 58521,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">AD</span></span></span></span></span></p>"
      },
      {
        "id": 58522,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">AR</span></span></span></span></span></p>"
      },
      {
        "id": 58523,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">XLD</span></span></span></span></span></p>"
      },
      {
        "id": 58524,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">XLR</span></span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">What is the type of inheritance shown in the Image: (FMGE JAN 2023)</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-25-191705.jpg\" style=\"height:235px; width:350px\" /></span></span></span></span></span></p>",
    "unique_key": "Q4612694",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676632,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. A) AD</span></span></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Notice that the disease is present in all 3 generations. It is being transmitted from affected father to his daughter and son. Also, it is being transmitted from affected mother to her progeny. So, it is autosomal dominant mode of inheritance.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. AR (Autosomal Recessive):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Typically, AR inheritance shows disease in siblings, not across multiple generations, and both parents must be carriers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. XLD (X-linked Dominant):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Affected fathers would transmit the disease to all daughters but not sons, and affected mothers can transmit to both sons and daughters.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. XLR (X-linked Recessive):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> More common in males; females are typically carriers unless they have two affected X chromosomes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;The presence of the disease in all three generations and transmission from both affected fathers and mothers to their progeny indicates autosomal dominant (AD) inheritance.</span></span></span></p>",
    "correct_choice_id": 58521,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "FMGE",
      "ImageBased",
      "InvestigationBased"
    ]
  },
  {
    "id": 10464,
    "choices": [
      {
        "id": 41822,
        "text": "<p><span style=\"font-size:12.0pt;\">Thick layer of fibrin lining the alveoli</span></p>"
      },
      {
        "id": 41823,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute and chronic alveolar hemorrhage</span></p>"
      },
      {
        "id": 41824,
        "text": "<p><span style=\"font-size:12.0pt;\">Perivascular cuffing</span></p>"
      },
      {
        "id": 41825,
        "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary artery hypertrophy with increased resistance</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old man was diagnosed with COVID-19 and was put on mechanical ventilation. He passed away after a week. What is the likely post-mortem change seen in the lungs? (NEET PG 2022)</span></p>",
    "unique_key": "Q6058650",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676656,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Thick layer of fibrin lining the alveoli</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a patient with severe COVID-19 who was on mechanical ventilation, the likely post-mortem change seen in the lungs is, thick layer of fibrin lining the alveoli.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">COVID-19 is known to cause severe respiratory illness, and in severe cases, patients may require mechanical ventilation. One of the characteristic features of severe COVID-19 pneumonia is the development of acute respiratory distress syndrome (ARDS). ARDS is characterized by diffuse alveolar damage, including the accumulation of fibrin-rich hyaline membranes lining the alveolar walls. This can result in the formation of a thick layer of fibrin lining the alveoli, leading to impaired gas exchange and respiratory failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While acute and chronic alveolar hemorrhage, perivascular cuffing, and pulmonary artery hypertrophy with increased resistance may be seen in other respiratory diseases, they are not typically associated with severe COVID-19 pneumonia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Acute and chronic alveolar hemorrhage</strong>: This may be seen in conditions like vasculitis or certain types of pneumonia but is not a hallmark of severe COVID-19.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Perivascular cuffing</strong>: This refers to lymphocytic infiltration around blood vessels and is more common in viral myocarditis and certain chronic lung diseases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pulmonary artery hypertrophy with increased resistance</strong>: This is typically associated with chronic pulmonary hypertension and not an immediate feature of severe COVID-19 pneumonia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with severe COVID-19, especially those who have been on mechanical ventilation, the likely post-mortem finding in the lungs is a thick layer of fibrin lining the alveoli, indicative of acute respiratory distress syndrome (ARDS) and severe diffuse alveolar damage.</span></p>",
    "correct_choice_id": 41822,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 48126,
    "choices": [
      {
        "id": 192099,
        "text": "<p><span style=\"font-size:12.0pt;\">Myelodysplastic syndrome</span></p>"
      },
      {
        "id": 192100,
        "text": "<p><span style=\"font-size:12.0pt;\">Idiopathic thrombocytopenic purpura</span></p>"
      },
      {
        "id": 192101,
        "text": "<p><span style=\"font-size:12.0pt;\">Thrombotic thrombocytopenic purpura</span></p>"
      },
      {
        "id": 192102,
        "text": "<p><span style=\"font-size:12.0pt;\">Chloramphenicol toxicity</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;Pawn ball megakaryocytes are characteristic of: (NEET PG 2015)</span></p>",
    "unique_key": "Q7017281",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676654,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Correct Answer: A. Myelodysplastic syndrome.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pawn ball megakaryocytes are a characteristic morphological finding in myelodysplastic syndromes (MDS). These abnormal megakaryocytes have separated nuclear lobes instead of the normal single multi-lobated nucleus. The presence of these distinctive megakaryocytes is part of the dysmegakaryopoiesis that occurs in MDS, along with other features like ringed sideroblasts and pseudo-Pelger-Huet neutrophils. These morphological abnormalities reflect the underlying maturation defect at the level of myeloid stem cells that characterizes MDS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Idiopathic thrombocytopenic purpura</strong> - This is incorrect. In ITP, megakaryocytes are typically normal or increased in number, but they do not show the characteristic pawn ball morphology. ITP is an immune-mediated disorder characterized by antibody destruction of platelets.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Thrombotic thrombocytopenic purpura</strong> - This is incorrect. TTP is characterized by microthrombi formation due to abnormally large von Willebrand factor multimers. The bone marrow findings in TTP do not typically include pawn ball megakaryocytes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chloramphenicol toxicity</strong> - This is incorrect. Chloramphenicol toxicity can cause bone marrow suppression and aplasia, but it is not specifically associated with pawn ball megakaryocytes. It tends to cause a general hypocellularity rather than dysplastic changes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pawn ball megakaryocytes, with their distinctive separated nuclear lobes, are a characteristic morphological finding in myelodysplastic syndromes and reflect the dysplastic changes in megakaryopoiesis that are a hallmark of this group of disorders.</span></p>",
    "correct_choice_id": 192099,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 54943,
    "choices": [
      {
        "id": 219233,
        "text": "<p><span style=\"font-size:12.0pt;\">5-HIAA</span></p>"
      },
      {
        "id": 219234,
        "text": "<p><span style=\"font-size:12.0pt;\">Calcitonin</span></p>"
      },
      {
        "id": 219235,
        "text": "<p><span style=\"font-size:12.0pt;\">Catecholamine</span></p>"
      },
      {
        "id": 219236,
        "text": "<p><span style=\"font-size:12.0pt;\">Dopamine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a tumor marker of carcinoid tumor? (FMGE JULY 2024)</span></p>",
    "unique_key": "Q1226724",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676624,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A) 5-HIAA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Carcinoid tumors originate from enterochromaffin cells, which are rich in serotonin (5-hydroxytryptamine). Serotonin is metabolized to 5-hydroxyindoleacetic acid (5-HIAA), which is excreted in the urine. Elevated levels of 5-HIAA in the urine are indicative of a carcinoid tumor, particularly when the tumor is active and producing excessive serotonin. This makes 5-HIAA a reliable tumor marker for diagnosing and monitoring carcinoid tumors and the associated carcinoid syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Calcitonin:</strong> Calcitonin is a tumor marker for medullary thyroid carcinoma, not carcinoid tumors. It is used to monitor patients with medullary thyroid cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Catecholamine:</strong> Catecholamines are associated with adrenal medullary tumors, such as pheochromocytoma. They are not specific for carcinoid tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Dopamine:</strong> Dopamine is a neurotransmitter and is not used as a tumor marker for carcinoid tumors. It is associated with different physiological and pathological processes, but not directly with carcinoid tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinically, patients with carcinoid syndrome may present with a range of symptoms including hepatomegaly, bronchospasm that mimics asthma, episodes of vasoconstriction affecting blood vessels, increased intestinal motility manifesting as diarrhea, and distinctive flushing of the skin. The co-occurrence of symptoms like diarrhea, asthma-like respiratory issues, and hepatomegaly should immediately suggest the possibility of carcinoid syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">An increase in the levels of 5-HIAA in blood and urine is a significant indicator (primary tumor marker) of carcinoid syndrome.</span></p>",
    "correct_choice_id": 219233,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE",
      "InvestigationBased"
    ]
  },
  {
    "id": 10070,
    "choices": [
      {
        "id": 40246,
        "text": "<p><span style=\"font-size:12.0pt;\">Osteosarcoma</span></p>"
      },
      {
        "id": 40247,
        "text": "<p><span style=\"font-size:12.0pt;\">Ewing sarcoma</span></p>"
      },
      {
        "id": 40248,
        "text": "<p><span style=\"font-size:12.0pt;\">Metastatic neuroblastoma</span></p>"
      },
      {
        "id": 40249,
        "text": "<p><span style=\"font-size:12.0pt;\">Osteoclastoma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 15-year-old boy is brought to OPD with swelling in the upper part of the tibia. X-ray revealed periosteal reaction in upper diaphysis of tibia. A histopathological image of the biopsy is given below. Immunohistochemistry was positive for Synaptophysin and MIC-2. What is the likely diagnosis?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(INICET MAY 2022)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture4.jpg\" alt=\"\" width=\"300\" height=\"226\"></p>",
    "unique_key": "Q3902469",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676652,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Ewing sarcoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given clinical scenario, immunohistochemistry showing positive for Synaptophysin and MIC-2 with histopath image showing small round blue cells, points to a diagnosis of Ewing\u2019s sarcoma.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture5.jpg\" alt=\"\" width=\"800\" height=\"421\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong></span><span style=\"font-size:14.6667px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Osteosarcoma</strong></span><span style=\"font-size:12pt;\">: Osteosarcoma is an osteoid forming tumor. Patient usually complains of Night pain. But it neither shows small round blue cells on biopsy nor is positive for MIC-2</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Metastatic</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>neuroblastoma</strong>: Metastatic neuroblastoma also shows Homer wright pseudo rosettes, but it is positive for NSE, PHOX 28.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Osteoclastoma (Giant cell tumor)</strong>: Osteoclastoma is a benign, locally aggressive bone tumor that is characterized by the presence of multinucleated giant cells on biopsy. It typically affects the epiphysis of long bones and does not present with small round blue cells or positive staining for MIC-2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ewing sarcoma is a small round blue cell tumor commonly occurring in the diaphysis of long bones in adolescents. It is characterized by positive immunohistochemical staining for Synaptophysin and MIC-2 (CD99).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins pathologic basis of disease 8th edition pg 2390-2391</strong></span></p>",
    "correct_choice_id": 40247,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 10021,
    "choices": [
      {
        "id": 40050,
        "text": "<p><span style=\"font-size:12.0pt;\">2 only</span></p>"
      },
      {
        "id": 40051,
        "text": "<p><span style=\"font-size:12.0pt;\">3 only</span></p>"
      },
      {
        "id": 40052,
        "text": "<p><span style=\"font-size:12.0pt;\">1 and 4</span></p>"
      },
      {
        "id": 40053,
        "text": "<p><span style=\"font-size:12.0pt;\">2 and 3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is true about proto-oncogenes? (INICET NOV 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">KIT has decreased expression in GIST.</span></li><li><span style=\"font-size:12.0pt;\">KRAS mutation is more commonly associated with small-cell lung carcinoma.</span></li><li><span style=\"font-size:12.0pt;\">ERBB2 over-expression is associated with breast carcinomas.</span></li><li><span style=\"font-size:12.0pt;\">PDGFR-\u03b2 has suppressed expression in colorectal cancers.</span></li></ol>",
    "unique_key": "Q9071693",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676626,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 3 Only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ERBB2, also known as HER2, is a proto-oncogene that encodes a receptor tyrosine kinase. Overexpression of HER2 is strongly associated with breast carcinomas, specifically HER2-positive breast cancers. HER2 is a significant marker in breast cancer, as its overexpression or amplification can lead to more aggressive tumor growth and is a target for specific therapies like trastuzumab.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-121654.jpg\" alt=\"\" width=\"1000\" height=\"788\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-121749.jpg\" alt=\"\" width=\"1000\" height=\"662\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. KIT has decreased expression in GIST (Gastrointestinal Stromal Tumors)</strong>:&nbsp;This statement is incorrect. KIT, also known as CD117, is commonly overexpressed in GISTs. The detection of KIT is often used diagnostically to confirm GIST.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. KRAS mutation is more commonly associated with small-cell lung carcinoma</strong>:&nbsp;This statement is incorrect. KRAS mutations are more commonly associated with non-small cell lung carcinoma (NSCLC), particularly adenocarcinoma of the lung, as well as colorectal and pancreatic cancers.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. PDGFR-\u03b2 has suppressed expression in colorectal cancers</strong>:&nbsp;This statement is incorrect. PDGFR-\u03b2 (Platelet-derived growth factor receptor beta) is generally overexpressed in gliomas and leukemias, rather than being suppressed in colorectal cancers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">ERBB2 encodes for HER2, which is involved in Breast carcinoma. ERBB1 encodes for EGFR, which is involved in Adenocarcinoma of lung.</span></li><li><span style=\"font-size:12.0pt;\">Genes involved in GIST are \u2192 DOG1 &gt; CD117 (cKIT) &gt; CD34</span></li><li><span style=\"font-size:12.0pt;\">KRAS mutations are cause of Lung, colorectal and pancreatic carcinoma. Gain of function mutation is seen in Adenocarcinoma of lung.</span></li><li><span style=\"font-size:12.0pt;\">PDGFR-\u03b2 over-expression is seen in Glioma and Leukemia.</span></li></ul>",
    "correct_choice_id": 40051,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 57626,
    "choices": [
      {
        "id": 229873,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum copper</span></span></p>"
      },
      {
        "id": 229874,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary copper</span></span></p>"
      },
      {
        "id": 229875,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver copper levels</span></span></p>"
      },
      {
        "id": 229876,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum ceruloplasmin</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient had a history of hepatic dysfunction, and the physical examination finding of the eye is shown below. Which of the following is the best way for confirmation of the diagnosis in this patient? (NEET PG 2024)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/pathology-neet-pg-aug-2024-pdf4.jpg\" style=\"height:296px; width:300px\" /></span></span></p>",
    "unique_key": "Q2509717",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676622,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Liver copper levels</strong></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The image shows a <strong>Kayser-Fleischer ring,</strong> which is a brownish or gray-green ring at the corneal margin, characteristic of Wilson&#39;s disease. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Wilson&#39;s disease is a disorder of copper metabolism leading to the accumulation of copper in various body tissues, including the liver, brain, and eyes. The Kayser-Fleischer ring, combined with hepatic dysfunction, strongly suggests Wilson&rsquo;s disease. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most reliable method for confirming the diagnosis of Wilson&rsquo;s disease is measuring liver copper levels. Elevated hepatic copper content (greater than 250 &micro;g/g dry weight) is diagnostic of Wilson&rsquo;s disease, reflecting the abnormal accumulation of copper in liver tissue.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Serum copper:</span></strong><span style=\"font-size:12.0pt\"> Serum copper levels are usually low in Wilson&rsquo;s disease because copper is not adequately bound to ceruloplasmin. However, this test is not specific or reliable enough to confirm the diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Urinary copper:</span></strong><span style=\"font-size:12.0pt\"> Urinary copper excretion is typically elevated in Wilson&#39;s disease and can be used as a supportive test but is not the gold standard for confirmation. It is often used to monitor treatment response rather than for initial diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Serum ceruloplasmin:</span></strong><span style=\"font-size:12.0pt\"> Serum ceruloplasmin levels are often low in Wilson&#39;s disease, but this is not specific and can be influenced by other factors, making it unreliable as a sole diagnostic tool.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Liver copper levels measured from a liver biopsy are the most definitive and confirmatory test for diagnosing Wilson&rsquo;s disease, especially when characteristic signs like Kayser-Fleischer rings are present.</span></span></span></p>",
    "correct_choice_id": 229875,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 43960,
    "choices": [
      {
        "id": 175503,
        "text": "<p><span style=\"font-size:12.0pt;\">Direct immunofluorescence</span></p>"
      },
      {
        "id": 175504,
        "text": "<p><span style=\"font-size:12.0pt;\">ELISA</span></p>"
      },
      {
        "id": 175505,
        "text": "<p><span style=\"font-size:12.0pt;\">Indirect immunofluorescence</span></p>"
      },
      {
        "id": 175506,
        "text": "<p><span style=\"font-size:12.0pt;\">FISH</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which technique is used to identify auto antibodies?</span> <span style=\"font-size:12.0pt;\">(INICET NOV 2023)</span></p>",
    "unique_key": "Q5506022",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676638,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Indirect immunofluorescence</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Indirect immunofluorescence is a technique commonly used for the detection of autoantibodies. It involves applying the patient's serum to a substrate that expresses the antigen(s) of interest. If autoantibodies are present, they bind to these antigens. Then another anti-human antibody is added to amplify the response generated.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Direct Immunofluorescence:&nbsp;</strong>Used for tissue-bound antibodies where the patient's tissues are stained directly to detect deposits of immunoglobulins or complement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. ELISA</strong>: Mainly used for quantifying serum levels of specific antibodies against predefined antigens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. FISH (Fluorescent In Situ Hybridization)</strong>: Used for identifying chromosomal abnormalities and gene mutations rather than detecting antibodies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Indirect immunofluorescence allows for the detection of circulating autoantibodies in patient serum by using antigen-expressing substrates, making it a critical tool for diagnosing various autoimmune diseases.</span></p>",
    "correct_choice_id": 175505,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "InvestigationBased"
    ]
  },
  {
    "id": 9971,
    "choices": [
      {
        "id": 39850,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute monocytic leukemia</span></p>"
      },
      {
        "id": 39851,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute myelomonocytic leukemia</span></p>"
      },
      {
        "id": 39852,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute lymphoblastic leukemia</span></p>"
      },
      {
        "id": 39853,
        "text": "<p><span style=\"font-size:12.0pt;\">Juvenile myelomonocytic leukemia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 10-year-old boy with fever, weight loss came to the hospital. On examination, he was pale and had significant lymphadenopathy. The bone marrow histology of the person is as given below. Your diagnosis is: (AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/51.jpg\" alt=\"\" width=\"300\" height=\"240\"></span></p>",
    "unique_key": "Q1656582",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676664,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Acute lymphoblastic leukemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given scenario with bone marrow histology showing lymphoblasts (condensed nuclear chromatin, small nucleoli, scanty agranular cytoplasm) is suggestive of acute lymphoblastic leukemia.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-161555.png\" alt=\"\" width=\"500\" height=\"215\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">PBF Findings in acute lymphoblastic (ALL). The cell is large, with round to convoluted nuclei having high N/C ratio and no cytoplasmic granularity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ALL is more common in childhood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinical features of ALL include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Bone marrow failure - anemia, fever, infections, bleeding</span></li><li><span style=\"font-size:12.0pt;\">Mass effects due to neoplastic infiltration - bone pain, generalized lymphadenopathy, splenomegaly, hepatomegaly, and testicular enlargement</span></li><li><span style=\"font-size:12.0pt;\">CNS manifestations - headache, vomiting, and <strong>nerve palsies</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>B-ALL</strong> - Pancytopenia due to marrow involvement</span></li><li><span style=\"font-size:12.0pt;\"><strong>T-ALL</strong> - Mediastinal mass, compression of large vessels and airways in the mediastinum, lymphadenopathy, splenomegaly</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-171159.png\" alt=\"\" width=\"1000\" height=\"341\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Acute monocytic leukemia</strong> and <strong>Option&nbsp;B. Acute myelomonocytic leukemia</strong>: These leukemias typically present with different morphologic features, including monoblasts and myeloblasts, which show different cytological characteristics such as cytoplasmic granularity and different nuclear morphology.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Juvenile myelomonocytic leukemia (JMML)</strong>: JMML is a rare childhood leukemia with a different clinical presentation, often including hepatosplenomegaly and elevated monocyte counts, and it does not present with the lymphoblast morphology seen in ALL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acute lymphoblastic leukemia (ALL) in children is characterized by the presence of lymphoblasts in the bone marrow and peripheral blood, along with clinical features of bone marrow failure and organ infiltration by malignant cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbin and Cotran pathologic basis of disease, 8<sup>th</sup> edition, Page No. 1113</strong></span></p>",
    "correct_choice_id": 39852,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "ImageBased"
    ]
  },
  {
    "id": 9780,
    "choices": [
      {
        "id": 39087,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ferroportin</span></span></span></p>"
      },
      {
        "id": 39088,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Transferrin</span></span></span></p>"
      },
      {
        "id": 39089,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Divalent metal transporter 1 (DMT1)</span></span></span></p>"
      },
      {
        "id": 39090,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ferritin</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepcidin inhibits iron transfer from the enterocyte to the plasma by binding to?</span></span> (AIIMS MAY 2019)</p>",
    "unique_key": "Q4971777",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676637,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Ferroportin</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hepcidin inhibits iron transfer from the enterocyte to plasma by binding to ferroportin.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Iron absorption is regulated by hepcidin, a small circulating peptide that is synthesized and released from the liver in response to increases in intrahepatic iron levels.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hepcidin inhibits iron transfer from the enterocyte to plasma by binding to ferriportin and causing it to be endocytosed and degraded. As a result, as hepcidin levels rise, iron becomes trapped within duodenal cells in the form of mucosal ferritin and is lost as these cells are sloughed. Thus, when the body is replete with iron, high hepcidin levels inhibit its absorption into the blood.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Conversely, with low body stores of iron, hepcidin synthesis falls and this in turn facilitates iron absorption. By inhibiting ferriportin, hepcidin not only reduces iron uptake from enterocytes but also suppresses iron release from macrophages, which are an important source of the iron that is used by erythroid precursors to make hemoglobin.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Transferrin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Transferrin is a plasma protein that binds iron in the blood and transports it to various tissues, particularly the bone marrow for erythropoiesis. Hepcidin does not bind to transferrin; instead, it regulates iron export through ferroportin.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Divalent metal transporter 1 (DMT1)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: DMT1 is involved in the uptake of iron (in its ferrous form) from the lumen of the intestine into enterocytes. Hepcidin does not interact with DMT1; its regulatory effect occurs after iron has been absorbed into enterocytes, at the point of iron export into the bloodstream via ferroportin.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Ferritin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Ferritin is the intracellular protein that stores iron in a soluble and non-toxic form. Hepcidin does not bind to ferritin directly. However, by reducing the expression of ferroportin, hepcidin indirectly increases the storage of iron within cells in the form of ferritin.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hepcidin regulates iron homeostasis by binding to ferroportin, leading to its degradation, which prevents iron export from enterocytes into the plasma and from macrophages.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: Robbin and Cotran pathologic basis of disease, 8th edition, Pg 1231</span></strong></span></span></p>",
    "correct_choice_id": 39087,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 9974,
    "choices": [
      {
        "id": 39862,
        "text": "<p><span style=\"font-size:12.0pt;\">Raynaud phenomenon and sclerodactyly</span></p>"
      },
      {
        "id": 39863,
        "text": "<p><span style=\"font-size:12.0pt;\">Genital and oral painful ulcers</span></p>"
      },
      {
        "id": 39864,
        "text": "<p><span style=\"font-size:12.0pt;\">Glomerulonephritis and heart failure</span></p>"
      },
      {
        "id": 39865,
        "text": "<p><span style=\"font-size:12.0pt;\">Joint pains with nodules on skin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old female with history of back ache and polyarthralgia was investigated and found to have nucleolar pattern in IF. Which of the following is the best fit in her case?</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2017)</span></p>",
    "unique_key": "Q6836706",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676666,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Raynaud phenomenon and sclerodactyly</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Nucleolar pattern refers&nbsp;</strong>to the presence of a few discrete spots of fluorescence within the nucleus and represents antibodies to RNA. This pattern is reported most often in patients with systemic sclerosis. Hence, Raynaud phenomenon and sclerodactyly will be seen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/54.jpg\" alt=\"\" width=\"409\" height=\"293\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Systemic sclerosis&nbsp;</strong>is more common in middle-aged women. The clinical manifestations include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Claw-like flexion deformity of hands</span></li><li><span style=\"font-size:12.0pt;\"><strong>Raynaud\u2019s phenomenon</strong> - manifested as episodic vasoconstriction of the arteries and arterioles of the extremities, is seen in virtually all patients and <strong>precedes other symptoms</strong> in 70% of cases</span></li><li><span style=\"font-size:12.0pt;\">Esophageal fibrosis causing dysphagia and hypomotility</span></li><li><span style=\"font-size:12.0pt;\">Malabsorption syndrome</span></li><li><span style=\"font-size:12.0pt;\">Respiratory distress due to pulmonary fibrosis</span></li><li><span style=\"font-size:12.0pt;\">Malignant hypertension</span></li><li><span style=\"font-size:12.0pt;\">Pulmonary hypertension</span></li><li><span style=\"font-size:12.0pt;\">Biliary cirrhosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other IF Patterns: -</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Examples of ICAP-classified IIFA staining patterns:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-160908.png\" alt=\"\" width=\"600\" height=\"258\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-171539.png\" alt=\"\" width=\"1000\" height=\"755\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>ENA: Extractable nuclear antigens; RNP; ribonucleoproteins; SLE; systemic lupus erythematous; MCTD: mixed connective tissue disease; PM: polymyositis; d<sub>s</sub>DNA: double-stranded deoxyribonucleic acid; CENP: centromere protein</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Genital and oral painful ulcers</strong>: These are more characteristic of <strong>Beh\u00e7et's disease</strong>, which is associated with HLA-B51 and presents with recurrent oral and genital ulcers, uveitis, and other systemic symptoms, not a nucleolar pattern on IF.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Glomerulonephritis and heart failure</strong>: These features are more consistent with <strong>systemic lupus erythematosus (SLE)</strong>, which may show a different pattern on IF, such as a homogenous or peripheral (rim) pattern, rather than the nucleolar pattern associated with systemic sclerosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Joint pains with nodules on skin</strong>: This description is typical of <strong>rheumatoid arthritis</strong>, which is associated with rheumatoid nodules and not the nucleolar pattern seen in systemic sclerosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The nucleolar pattern in IF is most often associated with systemic sclerosis, a condition characterized by Raynaud phenomenon and sclerodactyly, among other systemic manifestations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbin and Cotran pathologic basis of disease, 8th edition, Page No. 405, 425</strong></span></p>",
    "correct_choice_id": 39862,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 47546,
    "choices": [
      {
        "id": 189795,
        "text": "<p><span style=\"font-size:12.0pt;\">Retinoblastoma</span></p>"
      },
      {
        "id": 189796,
        "text": "<p><span style=\"font-size:12.0pt;\">Ocular melanoma</span></p>"
      },
      {
        "id": 189797,
        "text": "<p><span style=\"font-size:12.0pt;\">Rhabdomyosarcoma</span></p>"
      },
      {
        "id": 189798,
        "text": "<p><span style=\"font-size:12.0pt;\">Optic nerve glioma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 5-year-old child came with a lesion in the right eye and the histopathological image showed Flexner Wintersteiner rosettes. What is the likely diagnosis? (</span>FMGE Jan 2024)</p>",
    "unique_key": "Q9866927",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676640,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Retinoblastoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation of a lesion in the eye of a young child, along with the histopathological finding of Flexner-Wintersteiner rosettes (small round blue tumor cells), strongly suggests the diagnosis of retinoblastoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Retinoblastoma is a malignant tumor of the retina that primarily affects young children. It arises from immature retinal cells called retinoblasts. The presence of Flexner-Wintersteiner rosettes is a characteristic histopathological feature of retinoblastoma. These rosettes are true rosettes, consisting of a ring of tumor cells surrounding a central lumen, resembling the primitive neuroepithelium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is important to distinguish Flexner-Wintersteiner rosettes from Homer Wright rosettes, which are pseudo-rosettes. Homer Wright rosettes are characterized by tumor cells arranged around a central neuropil (tangled cell processes) and are seen in various tumors of neuroectodermal origin, such as neuroblastoma and medulloblastoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-152809.png\" alt=\"\" width=\"600\" height=\"284\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While retinoblastoma can show both true rosettes (Flexner-Wintersteiner) and pseudo-rosettes (Homer Wright), the presence of true rosettes is more specific for retinoblastoma in the context of an ocular tumor in a young child.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ocular melanoma:&nbsp;</strong>Ocular melanoma is a malignant tumor arising from melanocytes in the eye. It is more common in adults and does not typically show Flexner-Wintersteiner rosettes on histopathology.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Rhabdomyosarcoma:&nbsp;</strong>Rhabdomyosarcoma is a malignant tumor of skeletal muscle origin. While it can occur in the orbit, it does not show Flexner-Wintersteiner rosettes on histopathology.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Optic nerve glioma:&nbsp;</strong>Optic nerve glioma is a benign tumor arising from glial cells of the optic nerve. It is more common in children with neurofibromatosis type 1 but does not typically show Flexner-Wintersteiner rosettes on histopathology.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of Flexner-Wintersteiner rosettes (true rosettes) on histopathology of an ocular lesion in a young child is highly suggestive of retinoblastoma. It is important to distinguish these true rosettes from Homer Wright pseudo-rosettes, which can be seen in various other neuroectodermal tumors.</span></p>",
    "correct_choice_id": 189795,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE"
    ]
  },
  {
    "id": 10318,
    "choices": [
      {
        "id": 41238,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Wilson&#39;s disease</span></span></span></p>"
      },
      {
        "id": 41239,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Autoimmune hepatitis</span></span></span></p>"
      },
      {
        "id": 41240,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alpha-1 antitrypsin deficiency</span></span></span></p>"
      },
      {
        "id": 41241,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemochromatosis</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55 yr old man is found to have hepatomegaly on physical examination. He also complains of dark tan despite avoiding sun exposure. His liver microscopy is given on the slide below. This patient most likely suffers from: (NEET PG 2019)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/3_UPDK5Dj.jpg\" style=\"height:204px; width:554px\" /></span></span></span></p>",
    "unique_key": "Q6519215",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676645,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Hemochromatosis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The patient most likely has hemochromatosis. The liver microscopy image in the given scenario shows hepatocellular iron deposition is dark-brown in H&amp;E stain (A) and blue in Prussian blue-stained section (B).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/4_5zZChi4.jpg\" style=\"height:182px; width:277px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemochromatosis is defined by an abnormally high accumulation of body iron, the majority of which is deposited in parenchymal organs such as the liver and pancreas. Iron can also build up in the heart, joints, and endocrine systems.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemochromatosis, also known as primary or hereditary hemochromatosis, is an inherited disorder caused by excessive iron absorption.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Secondary hemochromatosis, acquired hemochromatosis, or hemosiderosis refers to the accumulation of iron in tissues as a result of parenteral iron administration, usually in the form of transfusions, or other causes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Wilson&#39;s disease:</span></strong><span style=\"font-size:12.0pt\"> Primarily involves copper accumulation in the liver and other tissues, leading to liver disease and neuropsychiatric symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Autoimmune hepatitis:</span></strong><span style=\"font-size:12.0pt\"> Characterized by inflammation of the liver due to autoimmune disorders, not associated with iron deposition.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Alpha-1 antitrypsin deficiency:</span></strong><span style=\"font-size:12.0pt\"> Leads to liver and lung disease due to the accumulation of abnormal alpha-1 antitrypsin protein in the liver, not iron.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hemochromatosis is characterized by excessive iron deposition in the liver and other organs, which can be confirmed by the distinct staining patterns seen in liver biopsy samples.</span></span></span></p>",
    "correct_choice_id": 41241,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "OlderNEETPG"
    ]
  },
  {
    "id": 10071,
    "choices": [
      {
        "id": 40250,
        "text": "<p><span style=\"font-size:12.0pt;\">CD 68</span></p>"
      },
      {
        "id": 40251,
        "text": "<p><span style=\"font-size:12.0pt;\">CD 3</span></p>"
      },
      {
        "id": 40252,
        "text": "<p><span style=\"font-size:12.0pt;\">CD 25</span></p>"
      },
      {
        "id": 40253,
        "text": "<p><span style=\"font-size:12.0pt;\">CD 94</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a marker is expressed on natural killer cell?</span> <span style=\"font-size:12.0pt;\">(INICET MAY 2022)</span></p>",
    "unique_key": "Q8234862",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676653,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) CD 94</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Natural killer (NK) cells are a type of lymphocyte that play a critical role in the innate immune response, particularly in targeting virally infected cells and tumor cells. They are characterized by the expression of specific surface markers, including <strong>CD 16</strong>, <strong>CD 56</strong>, and <strong>CD 94</strong>. CD 94 is particularly important as it forms part of the receptor complex that NK cells use to recognize and interact with target cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong></span><span style=\"font-size:14.6667px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>CD 68</strong></span><span style=\"font-size:12pt;\">: CD 68 is a marker for macrophages and monocytes</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong></span><span style=\"font-size:14.6667px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>CD 3</strong></span><span style=\"font-size:12pt;\">: CD 3 is a pan T-cell marker</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. CD 25</strong>: CD 25 is a marker for IL2</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-115442.jpg\" alt=\"\" width=\"1000\" height=\"367\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins pathologic basis of disease 8th edition pg 356-357</strong></span></p>",
    "correct_choice_id": 40253,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 10435,
    "choices": [
      {
        "id": 41706,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dysplasia</span></span></span></p>"
      },
      {
        "id": 41707,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Carcinoma</span></span></span></p>"
      },
      {
        "id": 41708,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metaplasia</span></span></span></p>"
      },
      {
        "id": 41709,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyperplasia</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pap smear taken from a patient revealed hyperchromatic nuclei, irregular nuclear borders, and low maturation index involving the whole thickness but did not breach the basement membrane. What is the diagnosis? (NEET PG 2021)</span></span></p>",
    "unique_key": "Q8171641",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676641,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Dysplasia </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The hyperchromatic nuclei, irregular nuclear borders, and <strong>intact basement membrane</strong> are all suggestive of dysplasia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dysplasia is characterized by the loss in the uniformity of the individual cells and their architectural orientation.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The features of dysplasia include:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pleomorphism</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyperchromatic nuclei</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">High nuclear-to-cytoplasmic ratio</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased mitotic figures</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Carcinoma:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> In carcinoma, there is the invasion of the basement membrane.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Metaplasia:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> It refers to the replacement of one cell type with another type. It is almost always associated with tissue damage, repair, and regeneration. The most common epithelial metaplasia is columnar to squamous.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Hyperplasia: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It refers to the increase in the number of cells in a tissue or organ. It can be physiologic or pathological. Enlargement of the female breast during pregnancy is physiologic hyperplasia. Endometrial hyperplasia is an example of pathological hyperplasia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/17/untitled-474.jpg\" style=\"height:285px; width:500px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dysplasia is characterized by abnormal cellular features such as pleomorphism, hyperchromatic nuclei, increased mitotic figures, and a high nuclear-to-cytoplasmic ratio. It involves the entire thickness of the epithelium without breaching the basement membrane, distinguishing it from carcinoma, which involves invasion beyond the basement membrane.</span></span></span></p>",
    "correct_choice_id": 41706,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 65283,
    "choices": [
      {
        "id": 260305,
        "text": "<p><span style=\"font-size:12.0pt;\">Stop the blood transfusion and perform a direct Coombs test</span></p>"
      },
      {
        "id": 260306,
        "text": "<p><span style=\"font-size:12.0pt;\">Continue the blood transfusion and monitor urine output</span></p>"
      },
      {
        "id": 260307,
        "text": "<p><span style=\"font-size:12.0pt;\">Administer antipyretics and continue transfusion</span></p>"
      },
      {
        "id": 260308,
        "text": "<p><span style=\"font-size:12.0pt;\">Investigate for hemolysis after completing the transfusion</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old male with a history of sickle cell anemia undergoes a blood transfusion. During the transfusion, he develops fever, chills, back pain, and dark urine. What is the next appropriate step in the management of this patient? (Twisted PYQ)</span></p>",
    "unique_key": "Q1093659",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676615,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Stop the blood transfusion and perform a direct Coombs test</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The presentation of fever, chills, back pain, and dark urine during a blood transfusion is suggestive of <strong>acute hemolytic transfusion reaction (AHTR)</strong>, often caused by ABO incompatibility or alloantibody-mediated hemolysis. The immediate step is to <strong>stop the transfusion</strong> to prevent further hemolysis and systemic complications. A <strong>direct Coombs test</strong> is essential to confirm hemolysis and identify the underlying cause. Other supportive measures, such as maintaining adequate hydration and monitoring renal function, should also be undertaken.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong> Continuing the blood transfusion is inappropriate as it would exacerbate the hemolytic reaction and lead to further complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong> Administering antipyretics may mask symptoms but does not address the underlying hemolytic process and is unsafe to do without stopping the transfusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> Investigating for hemolysis is crucial but should be done immediately after stopping the transfusion, not after completing it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">In suspected acute hemolytic transfusion reactions, characterized by fever, back pain, dark urine, and systemic symptoms, the immediate priority is to stop the transfusion and confirm hemolysis using a direct Coombs test. Prompt intervention is crucial to prevent renal damage and other complications.</span></p>",
    "correct_choice_id": 260305,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 9850,
    "choices": [
      {
        "id": 39366,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Na-EDTA</span></span></span></p>"
      },
      {
        "id": 39367,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Trisodium citrate</span></span></span></p>"
      },
      {
        "id": 39368,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">NAF</span></span></span></p>"
      },
      {
        "id": 39369,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Clot activator</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The vacutainer tube shown in the given image contains: (AIIMS MAY 2020) </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/981.jpg\" style=\"height:255px; width:300px\" /></span></span></span></span></p>",
    "unique_key": "Q6283535",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676668,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Clot Activator</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">The plastic tube shown in the given image has a red stopper indicating that it contains clot activator (silica). They don&rsquo;t contain anticoagulants or additives.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">The tube is inverted five times to initiate the clotting process.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Na-EDTA</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Na-EDTA is an anticoagulant used in vacutainer tubes with <strong>lavender or purple stoppers</strong>. These tubes are used for hematological examinations such as complete blood counts (CBC) and erythrocyte sedimentation rate (ESR).</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Trisodium citrate</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Trisodium citrate is found in tubes with <strong>light blue stoppers</strong> and is used for coagulation studies such as PT (Prothrombin Time) and APTT (Activated Partial Thromboplastin Time).</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. NAF (Sodium Fluoride)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Sodium fluoride is an anticoagulant and preservative found in tubes with <strong>gray stoppers</strong>. It is used for glucose estimation as it inhibits glycolysis.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/982.jpg\" style=\"height:996px; width:692px\" /></span></span></span></span></p>",
    "correct_choice_id": 39369,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ImageBased",
      "InstrumentsBased"
    ]
  },
  {
    "id": 10376,
    "choices": [
      {
        "id": 41470,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Peutz Jegher syndrome</span></span></span></p>"
      },
      {
        "id": 41471,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Villous adenoma</span></span></span></p>"
      },
      {
        "id": 41472,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Juvenile polyp</span></span></span></p>"
      },
      {
        "id": 41473,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tubular adenoma</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 5-year-old child was admitted to the hospital with a history of prolapsing rectal mass and painless rectal bleeding. The histopathological image of the mass is as shown below. What is the most likely diagnosis? (NEET PG 2020)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/11_NYoMXMt.jpg\" style=\"height:283px; width:194px\" /></span></span></span></p>",
    "unique_key": "Q3184456",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676616,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Juvenile Polyp </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The clinical features and the histopathological image showing characteristic <strong>cystically dilated crypts and glands</strong> are suggestive of a juvenile polyp.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Juvenile (retention) polyps</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> are mucosal epithelial and lamina propria malformations. These can be sporadic or syndromic, but their morphology is often indistinguishable. The vast majority of juvenile polyps are found in children under the age of five. When found in adults, polyps with the same morphology are sometimes referred to as inflammatory polyps. The majority of juvenile polyps are in the rectum and cause painless rectal bleeding.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><u><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/12_HeDXLfy.jpg\" style=\"height:368px; width:253px\" /></u></span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Puetz Jegher syndrome:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Puetz Jegher syndrome&nbsp;is a rare autosomal dominant syndrome that manifests as multiple GI hamartomatous polyps and mucocutaneous hyperpigmentation at the age of 11 years.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/13_xQreBxn.jpg\" style=\"height:199px; width:400px\" /></span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/14_ipyODHz.jpg\" style=\"height:512px; width:500px\" /></span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Villous adenoma:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Villous adenomas are neoplastic and present with a different histopathological pattern of finger-like or villous projections.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">They are usually found in older adults and are not typically associated with painless rectal bleeding in children.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Tubular adenoma:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Tubular adenomas are intraepithelial neoplasms that can range from small polyps to large sessile lesions.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">They do not exhibit the cystically dilated glands seen in juvenile polyps and are also more common in older adults.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Note - Adenomas are intraepithelial neoplasms that range in size from small polyps to large sessile lesions. There is no preference for either gender, and both are present in nearly 50% of adults living in the Western world by age 50. Adenomas can be classified as <strong>tubular, tubulovillous, or villous based on their architecture</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/15_GkCeVLu.jpg\" style=\"height:231px; width:361px\" /></span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Juvenile polyps are the most common type of rectal polyps in children under five, characterized by cystically dilated crypts and glands, and often present with painless rectal bleeding.</span></span></span></p>",
    "correct_choice_id": 41472,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 9849,
    "choices": [
      {
        "id": 39362,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Light green SF</span></span></span></p>"
      },
      {
        "id": 39363,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Orange G</span></span></span></p>"
      },
      {
        "id": 39364,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Eosin B</span></span></span></p>"
      },
      {
        "id": 39365,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Hematoxylin</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not a component of Papanicolaou stain? </span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(AIIMS MAY 2020)</span></span></p>",
    "unique_key": "Q5625264",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676667,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Eosin B</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Eosin B is not a component of Papanicolaou stain</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Papanicolaou stain is the most popular stain used in the practice of histopathology. It is a polychrome stain containing multiple dyes to stain the various components of cells differentially. Papanicolaou stain includes both acidic and basic dyes:</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">The classic form of Pap stain involves five dyes in three solutions:</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">A nuclear stain<strong>, hematoxylin</strong>, is used to stain cell nuclei.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">First OG-6 counterstain. The <strong>Orange G</strong> is used to stain keratin.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Second EA (Eosin Azure) counterstain, comprising of three dyes</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Eosin Y</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"> stains the superficial epithelial squamous cells, nucleoli, cilia, and red blood cells.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Light Green SF</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"> yellowish stains the cytoplasm of all other cells. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Bismarck brown Y</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"> &ndash; omitted in contemporary formulations</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Light green SF</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This dye is used in the Pap stain to color the cytoplasm of various cells green.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Orange G</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This dye stains keratin and protein-rich components orange.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Hematoxylin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: A nuclear stain used to color cell nuclei blue-purple.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Eosin B is not a component of the Papanicolaou stain, which uses a combination of hematoxylin, Orange G, and Eosin Azure (including Eosin Y and Light Green SF) to differentially stain cellular components.</span></span></span></p>",
    "correct_choice_id": 39364,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 9781,
    "choices": [
      {
        "id": 39091,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Allergic</span></span></span></p>"
      },
      {
        "id": 39092,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Transfusion related circulatory overload</span></span></span></p>"
      },
      {
        "id": 39093,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Transfusion-related acute lung injury</span></span></span></p>"
      },
      {
        "id": 39094,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Febrile non-hemolytic transfusion reaction</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A CKD patient had to undergo dialysis and his Hb was 5.2gm/dL. So two blood transfusions were to be given. The first bag was completed in 2 hours. The second was started and in the midway, he developed shortness of breath and hypertension. Vitals Were BP - 180/120 mmHg and pulse rate - 110 min. What is the cause?&nbsp;</span></span>(AIIMS MAY 2019)</p>",
    "unique_key": "Q7606296",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676635,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Transfusion related circulatory overload</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The given clinical scenario is suggestive of transfusion-associated circulatory overload (TACO).</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Transfusion associated circulatory overload includes any four of the following occurring within 6 h of a blood transfusion - acute respiratory distress, tachycardia, increased blood pressure (BP), acute or worsening pulmonary edema and evidence of a positive fluid balance.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">TACO may occur due to rapid or excess transfusion of red cell preparations or plasma products.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prevented is by slow transfusion at the rate of 1 to 2 ml of blood/kg of body weight per hour. Diuretics are also used if necessary.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Allergic</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Allergic reactions to blood transfusions usually present with urticaria (hives), pruritus (itching), and sometimes anaphylaxis, but do not typically cause the significant hypertension and tachycardia seen in this case.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Transfusion-related acute lung injury (TRALI)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: TRALI is characterized by acute onset of non-cardiogenic pulmonary edema, leading to respiratory distress and hypoxemia during or within 6 hours of transfusion. However, TRALI typically presents with hypotension or normal blood pressure, not the significant hypertension seen here.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Febrile non-hemolytic transfusion reaction</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This reaction typically presents with fever, chills, and rigors, but does not cause the hemodynamic instability (hypertension and tachycardia) seen in TACO.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Transfusion-related circulatory overload (TACO) is a potential complication of blood transfusion, particularly in patients with predisposing conditions like CKD. It presents with respiratory distress, hypertension, and tachycardia and can be prevented by careful monitoring and slow transfusion.</span></span></span></p>",
    "correct_choice_id": 39092,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 10022,
    "choices": [
      {
        "id": 40054,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute lymphoblastic leukemia</span></span></span></p>"
      },
      {
        "id": 40055,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic lymphocytic leukemia</span></span></span></p>"
      },
      {
        "id": 40056,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute myeloid leukemia</span></span></span></p>"
      },
      {
        "id": 40057,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic myelogenous leukemia</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given peripheral smear is associated with which of the following leukemias? (INICET NOV 2022)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture2.jpg\" style=\"height:209px; width:300px\" /></p>",
    "unique_key": "Q2958277",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676627,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Chronic lymphocytic leukemia</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The peripheral smear findings point toward a diagnosis of chronic lymphocytic leukemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The blood contains large numbers of small round lymphocytes with scant cytoplasm. Some of these cells are usually disrupted in the process of making smears, producing <strong>so-called smudge cells</strong>. Lymphocytes are of same size and configuration with a uniform appearance <strong>called as &quot;convent-girl&quot; appearance.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Acute lymphoblastic leukemia (ALL)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The peripheral smear in ALL typically shows a high number of lymphoblasts, which are larger than normal lymphocytes and have a high nuclear-cytoplasmic ratio. There would be an absence of smudge cells, which are characteristic of CLL.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Acute myeloid leukemia (AML)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: AML is characterized by the presence of myeloblasts in the peripheral blood smear. These cells are larger, have more cytoplasm, and may contain Auer rods. Again, smudge cells are not a feature of AML.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Chronic myelogenous leukemia (CML)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The peripheral smear in CML shows a full spectrum of myeloid cells, from myeloblasts to mature neutrophils, often with an increase in basophils and eosinophils. Smudge cells are not a characteristic finding in CML.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-122634_v2GVwX7.jpg\" style=\"height:370px; width:1000px\" /></strong></span></span></span></p>",
    "correct_choice_id": 40055,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 57627,
    "choices": [
      {
        "id": 229877,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Melanoma</span></span></p>"
      },
      {
        "id": 229878,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphoma</span></span></p>"
      },
      {
        "id": 229879,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Retinoblastoma</span></span></p>"
      },
      {
        "id": 229880,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Squamous cell carcinoma</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A child presented with leukocoria and an intraocular mass, which on histopathological examination had the presence of Flexner-Wintersteiner rosettes. Which of the following is the likely diagnosis in the child? (NEET PG 2024)</span></span></span></p>",
    "unique_key": "Q4231375",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676623,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Retinoblastoma</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Retinoblastoma is the most common primary intraocular malignancy in children. The classical presentation includes leukocoria (white pupillary reflex) and an intraocular mass. Histopathologically, the presence of Flexner-Wintersteiner rosettes is a key diagnostic feature of retinoblastoma. These rosettes are true rosettes characterized by a circular arrangement of tumor cells around an empty lumen, resembling a flower.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In this case:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Leukocoria is a typical clinical presentation of retinoblastoma.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The intraocular mass in a child further supports this diagnosis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of Flexner-Wintersteiner rosettes confirms the diagnosis, as they are pathognomonic for retinoblastoma.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/pathology-neet-pg-aug-2024-pdf5.jpg\" style=\"height:252px; width:700px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Melanoma:</span></strong><span style=\"font-size:12.0pt\"> While melanoma can occur in the eye, it is more common in adults and typically does not present with leukocoria or Flexner-Wintersteiner rosettes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Lymphoma:</span></strong><span style=\"font-size:12.0pt\"> Intraocular lymphoma is rare in children and typically presents differently, without the characteristic rosettes seen in retinoblastoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Squamous cell carcinoma:</span></strong><span style=\"font-size:12.0pt\"> This malignancy affects the ocular surface and is not typically associated with intraocular masses or leukocoria. It also lacks the histological pattern of Flexner-Wintersteiner rosettes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Retinoblastoma is identified by leukocoria, an intraocular mass in children, and the presence of Flexner-Wintersteiner rosettes on histopathology, which are true rosettes specific to this diagnosis.</span></span></span></p>",
    "correct_choice_id": 229879,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 9806,
    "choices": [
      {
        "id": 39191,
        "text": "<p><span style=\"font-size:12.0pt;\">O</span></p>"
      },
      {
        "id": 39192,
        "text": "<p><span style=\"font-size:12.0pt;\">AB</span></p>"
      },
      {
        "id": 39193,
        "text": "<p><span style=\"font-size:12.0pt;\">B</span></p>"
      },
      {
        "id": 39194,
        "text": "<p><span style=\"font-size:12.0pt;\">A</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient has been brought with severe bleeding to your ER. His blood group is unknown. Fresh frozen plasma from which of the following blood groups can be given? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q2556086",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676647,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) AB</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">FFP from AB blood group can be given to this patient since the universal plasma donor is AB<strong>. AB plasma does not contain antibodies against antigens on RBCs of AB blood group.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Here, the question is about fresh frozen plasma transfusion and not about the packed red cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Had the question been about packed RBCs then in case of<strong> emergency packed cell blood transfusion with unknown blood group, O Rh-negative blood</strong> <strong>(universal donor) is transfused.</strong> It is preferred because it lacks the A and B and Rh antigens. Hence, it cannot be hemolyzed by anti-A, anti-B or anti-D antibodies in the recipient's blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-104002.png\" alt=\"\" width=\"1000\" height=\"917\"></p>",
    "correct_choice_id": 39192,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9807,
    "choices": [
      {
        "id": 39195,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">RAS</span></span></span></p>"
      },
      {
        "id": 39196,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">RET</span></span></span></p>"
      },
      {
        "id": 39197,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">BRAF</span></span></span></p>"
      },
      {
        "id": 39198,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">p53</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following proto-oncogenes is not implicated in carcinoma of thyroid? </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(AIIMS NOV 2018)</span></span></p>",
    "unique_key": "Q3081906",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676646,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) p53</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">p53 is a tumor suppressor gene, not a proto-oncogene like other 3 options.</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Proto-oncogenes are genes that, when mutated or overexpressed, have the potential to cause normal cells to become cancerous by promoting cell growth and division. On the other hand, tumor suppressor genes like p53 work to prevent uncontrolled cell growth. The p53 gene, often referred to as the &quot;guardian of the genome,&quot; plays a crucial role in regulating the cell cycle, DNA repair, and apoptosis (programmed cell death). When p53 is mutated, it can no longer effectively suppress tumor growth, leading to the development of cancer. However, p53 is not categorized as a proto-oncogene and is not directly implicated in thyroid carcinoma as an oncogenic driver.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Selected oncogenes, Their Mode of Activation, and Associated Human Tumors</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-104500.png\" style=\"height:961px; width:1000px\" /></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-180427_9gWSV27.png\" style=\"height:287px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and Cotrans pathologic basis of disease, 8<sup>th</sup> edition, Pg no 520</span></strong></span></span></p>",
    "correct_choice_id": 39198,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 24723,
    "choices": [
      {
        "id": 98853,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cirrhosis</span></span></span></p>"
      },
      {
        "id": 98854,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Creutzfeldt-Jakob disease</span></span></span></p>"
      },
      {
        "id": 98855,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nephritic syndrome</span></span></span></p>"
      },
      {
        "id": 98856,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sickle cell anemia</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following disorders is caused due to abnormal folding of proteins?</span></span> <span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2023)</span></span></p>",
    "unique_key": "Q5330460",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676621,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Creutzfeldt-Jakob disease</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Creutzfeldt-Jakob disease is caused due to abnormal folding of proteins.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CREUTZFELDT-JAKOB DISEASE (CJD)</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rare, degenerative, and fatal brain disorder.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Belongs to the group of transmissible spongiform encephalopathies (TSEs).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Results in the rapid deterioration of neurological function.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Causes</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Abnormal prion proteins (misfolded) accumulate in the brain, leading to nerve cell damage.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Can be sporadic, genetic, or acquired through contaminated medical procedures</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Symptoms</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rapidly progressive dementia.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Muscle stiffness, twitching, and weakness.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Behavioral changes, mood swings, and hallucinations.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Difficulty walking, speaking, and swallowing</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diagnosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Based on clinical symptoms, medical history, and neurological examination.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Brain imaging and cerebrospinal fluid analysis to rule out other conditions.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">No cure or specific treatment available.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Supportive care to manage symptoms and maintain quality of life.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Cirrhosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Primarily caused by chronic liver injury due to alcohol abuse, hepatitis, or other liver diseases, and is not related to abnormal protein folding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Nephritic syndrome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Characterized by inflammation of the glomeruli, leading to hematuria, hypertension, and proteinuria. The condition is generally caused by immune-mediated mechanisms, not by abnormal protein folding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Sickle cell anemia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: While it is caused by a protein mutation, it is not related to the abnormal folding of proteins.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Creutzfeldt-Jakob disease is a disorder caused by the abnormal folding of prion proteins, leading to severe and fatal brain degeneration.</span></span></span></p>",
    "correct_choice_id": 98854,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 14637,
    "choices": [
      {
        "id": 58509,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rb Gene </span></span></span></p>"
      },
      {
        "id": 58510,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">P53 Gene</span></span></span></p>"
      },
      {
        "id": 58511,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">P57 Gene</span></span></span></p>"
      },
      {
        "id": 58512,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RET</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which gene is commonly associated with the development of a round blue cell tumor in a child who underwent surgery for ocular malignancy? (FMGE JAN 2023)</span></span></span></p>",
    "unique_key": "Q7721811",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676628,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Rb gene </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gene responsible for the tumor development is Rb gene</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rb gene located on chromosome 13q14 its mutation seen in retinoblastoma it is the most common intraocular malignancy in children.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Imp. Clinical features of retinoblastoma:</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Leukocoria (White pupillary reflex)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Strabismus</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Painful red eye with secondary glaucoma</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. P53 Gene:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The P53 gene is a tumor suppressor gene involved in many cancers but not specifically in retinoblastoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. P57 Gene:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> P57 is involved in the regulation of cell cycle and growth but is not associated with retinoblastoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. RET:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The RET gene is involved in multiple endocrine neoplasia and medullary thyroid cancer, not retinoblastoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Rb gene mutation is responsible for retinoblastoma, the most common intraocular malignancy in children.</span></span></span></p>",
    "correct_choice_id": 58509,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 9933,
    "choices": [
      {
        "id": 39698,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin B12</span></span></span></p>"
      },
      {
        "id": 39699,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin B6</span></span></span></p>"
      },
      {
        "id": 39700,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin B1</span></span></span></p>"
      },
      {
        "id": 39701,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Iron</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following can be used in the treatment of sideroblastic anemia? (AIIMS MAY 2021) </span></span></span></p>",
    "unique_key": "Q9023689",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676644,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;<strong>B) Vitamin B6</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vitamin B6 (Pyridoxine) is used in the treatment of sideroblastic anemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The sideroblastic anemia comprise a group of disorders of diverse etiology in which the nucleated erythroid precursors in the bone marrow, show characteristic <strong>&lsquo;ringed sideroblasts.&rsquo;</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SIDEROCYTES&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">are red cells containing granules of non-haem iron. These granules stain ositively with Prussian blue reaction as well as stain with Romanowsky dyes where they are referred to as Pappenheimer bodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SIDEROBLASTS&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">are&nbsp;nucleated red cells (normoblasts) containing siderotic granules which stain positively with Prussian blue reaction. Depending upon the number, size and distribution of siderotic granules, sideroblasts may be normal or abnormal.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture22.jpg\" style=\"height:237px; width:400px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Vitamin B12</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Important for DNA synthesis and prevention of megaloblastic anemia but not directly involved in the treatment of sideroblastic anemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Vitamin B1</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Known as thiamine, involved in carbohydrate metabolism, but does not play a role in the treatment of sideroblastic anemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Iron</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Iron supplementation would not help and could worsen sideroblastic anemia, as the issue lies in the utilization of iron, not in its deficiency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vitamin B6 (Pyridoxine) is used in the treatment of sideroblastic anemia as it is a cofactor in the heme synthesis pathway and can correct the underlying metabolic defect in certain cases.</span></span></span></p>",
    "correct_choice_id": 39699,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 43962,
    "choices": [
      {
        "id": 175511,
        "text": "<p><span style=\"font-size:12.0pt;\">Low mechanical fragility, high osmotic fragility</span></p>"
      },
      {
        "id": 175512,
        "text": "<p><span style=\"font-size:12.0pt;\">High mechanical fragility, high osmotic fragility</span></p>"
      },
      {
        "id": 175513,
        "text": "<p><span style=\"font-size:12.0pt;\">Low mechanical fragility, low osmotic fragility</span></p>"
      },
      {
        "id": 175514,
        "text": "<p><span style=\"font-size:12.0pt;\">High mechanical fragility, low osmotic fragility</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is true about red blood cells in Sickle cell anemia:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(INICET NOV 2023)</span></p>",
    "unique_key": "Q8107597",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676639,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) High mechanical fragility, low osmotic fragility</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In sickle cell anemia, red blood cells (RBCs) have abnormal hemoglobin (HbS) that causes the cells to sickle under low oxygen conditions. These sickled cells are more prone to mechanical damage as they pass through the microcirculation, leading to increased mechanical fragility. However, their osmotic fragility is lower compared to normal RBCs because the sickling and subsequent damage to the cell membrane makes them less prone to osmotic lysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sickle cells exhibit high mechanical fragility due to their abnormal shape and membrane characteristics under stress but display low osmotic fragility because they are less prone to rupture in varying osmotic conditions compared to normal red blood cells.</span></p>",
    "correct_choice_id": 175514,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 10324,
    "choices": [
      {
        "id": 41262,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Caspase - 1</span></span></span></p>"
      },
      {
        "id": 41263,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Caspase - 3</span></span></span></p>"
      },
      {
        "id": 41264,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Caspase - 9</span></span></span></p>"
      },
      {
        "id": 41265,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Caspase &ndash; 8</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IL-1 is activated by: (NEET PG 2019)</span></span></p>",
    "unique_key": "Q3958273",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676651,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Caspase &ndash; 1 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Caspase- 1 activates the biologically active form of IL-1.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pyroptosis is a type of controlled cell death distinct from apoptosis and necrosis that is mediated by IL-1. It takes part in the removal of microbially and necrotically affected cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Caspase-1 and the inflammasome complex are both activated.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IL-1 production causes fever, inflammation, and leukocyte recruitment.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-125334.png\" style=\"height:562px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Options B. Caspase - 3, C. Caspase - 9&nbsp;</span></strong><span style=\"font-size:12.0pt\">and<strong> &nbsp;D. Caspase &ndash; 8:</strong> These caspases are primarily involved in the apoptosis pathway, not in the activation of IL-1. Caspase-3 and caspase-9 are part of the apoptotic cascade that leads to programmed cell death without inflammation. Caspase-8 is involved in extrinsic apoptosis signaling and can overlap with inflammatory pathways but does not directly activate IL-1.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Caspase-1 is critical for the activation of IL-1, directly linking it to the inflammatory response and distinguishing it from other caspases primarily involved in apoptotic pathways. This mechanism underscores the specific role of the inflammasome and pyroptosis in immune defense and inflammatory regulation.</span></span></span></p>",
    "correct_choice_id": 41262,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 24722,
    "choices": [
      {
        "id": 98849,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2</span></p>"
      },
      {
        "id": 98850,
        "text": "<p><span style=\"font-size:12.0pt;\">3, 4</span></p>"
      },
      {
        "id": 98851,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
      },
      {
        "id": 98852,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following are seen in iron deficiency anemia?</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2023)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Reduced serum iron level</span></li><li><span style=\"font-size:12.0pt;\">Reduced transferrin saturation</span></li><li><span style=\"font-size:12.0pt;\">Increased total iron binding capacity</span></li><li><span style=\"font-size:12.0pt;\">Reduced ferritin level</span></li></ol>",
    "unique_key": "Q6869994",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676619,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 1, 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Iron deficiency anemia (IDA) presents with lowered serum iron levels, decreased transferrin saturation, elevated total iron-binding capacity (TIBC), and diminished ferritin levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Reduced Serum Iron</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">What it is: This is the amount of circulating iron bound to transferrin in the blood.</span></li><li><span style=\"font-size:12.0pt;\">Why it decreases: In IDA, the body's iron stores are depleted due to chronic blood loss, poor dietary intake, or malabsorption, so there's less iron available to circulate.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Seen in IDA</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Reduced Transferrin Saturation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">What it is: This is the percentage of transferrin that is bound to iron.</span></li><li><span style=\"font-size:12.0pt;\">Transferrin Saturation=Serum Iron\u200b/TIBC\u00d7100</span></li><li><span style=\"font-size:12.0pt;\">Why it decreases: Since serum iron is low and TIBC is high, this ratio drops.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Seen in IDA</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Increased Total Iron-Binding Capacity (TIBC)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">What it is: This reflects the maximum amount of iron that transferrin can carry.</span></li><li><span style=\"font-size:12.0pt;\">Why it increases: The liver increases transferrin production in an attempt to capture more iron from the gut when body iron is low.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Seen in IDA</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Reduced Ferritin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">What it is: Ferritin is a protein that stores iron in cells and tissues.</span></li><li><span style=\"font-size:12.0pt;\">Why it decreases: In IDA, body iron stores are depleted, so ferritin levels drop.</span></li><li><span style=\"font-size:12.0pt;\">Important point: Ferritin is also an acute-phase reactant and may be elevated in inflammation, but in pure iron deficiency, it is low.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Seen in IDA</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Summary Table</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_gcEIJhK.png\" width=\"864\" height=\"224\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, the correct answer is:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">C. 1, 2, 3, 4 \u2014 all of these changes are classical features of iron deficiency anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/whatsapp-image-2023-07-04-at-125669.jpg\" alt=\"\" width=\"1000\" height=\"430\"></span></p>",
    "correct_choice_id": 98851,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 10379,
    "choices": [
      {
        "id": 41482,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Environmental enteropathy</span></span></span></p>"
      },
      {
        "id": 41483,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Celiac disease</span></span></span></p>"
      },
      {
        "id": 41484,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Whipple&#39;s disease</span></span></span></p>"
      },
      {
        "id": 41485,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic pancreatitis</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20-year-old patient presented to the clinic with a history of malabsorption, diarrhea, and poor appetite. Duodenal biopsy of the patient showed crypt hyperplasia, villi atrophy, and CD8+ cells in lamina propria. What is the most probable diagnosis? (NEET PG 2020)</span></span></p>",
    "unique_key": "Q2314349",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676617,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Celiac disease </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The clinical presentation and histopathological findings point to celiac disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Celiac disease is sometimes referred to as celiac sprue or gluten-sensitive enteropathy. In genetically predisposed individuals, it is an immune-mediated enteropathy triggered by the consumption of gluten-containing cereals such as <strong>Barley, Rye, Oat &amp; Wheat (BROW)</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Almost all celiac disease patients have the class II <strong>HLADQ2 or HLA-DQ8 allele.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Histopathology:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased numbers of <strong>intraepithelial CD8+ T lymphocytes</strong> (intraepithelial lymphocytosis), <strong>crypt hyperplasia</strong>, and <strong>villous atrophy</strong> characterize the histopathology.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/16_jyjVm3Q.jpg\" style=\"height:315px; width:602px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prior to biopsy, noninvasive serologic tests are usually performed. The presence of IgA antibodies to <strong>tissue transglutaminase or IgA</strong> or IgG antibodies to deamidated gliadin is the most sensitive test. <strong>Anti-endomysial antibodies are more specific than other antibodies but less sensitive</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical features: -</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Malabsorption syndrome&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">with chronic refractory <strong>anemia,</strong> chronic diarrhea, bloating, abdominal pain, and marked weight loss. A characteristic itchy, blistering skin lesion, <strong>dermatitis herpetiformis</strong>, can be present in as many as 10% of patients, and the incidence of lymphocytic gastritis and <strong>lymphocytic colitis</strong> is also increased.</span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Enteropathy associated T cell lymphoma</span></strong></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Small intestinal adenocarcinoma</span></strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment &ndash; <strong>Gluten free diet </strong>results in symptomatic improvement for most patients, but a gluten-free diet may also reduce the risk of long-term complications including anemia, female infertility, osteoporosis, and cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">DAPSONE&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">for dermatitis herpetiformis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Environmental enteropathy:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Environmental enteropathy / tropical sprue is seen in tropical areas with poor sanitation. It is believed to be caused by one or more infectious agents <strong>that respond to antibiotics</strong>. Mucosa shows variable villous atrophy. Folic acid and B12 deficiency is common.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Whipple&#39;s disease:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Whipple&#39;s disease is a multisystemic disease caused by T. whipplei. Small intestinal biopsy shows PAS-positive macrophages (see image below).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/19_m0TNFkQ.jpg\" style=\"height:266px; width:400px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Chronic pancreatitis:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Causes malabsorption due to exocrine pancreatic insufficiency. Not associated with the specific histopathological features seen in celiac disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Celiac disease is characterized by malabsorption, diarrhea, poor appetite, crypt hyperplasia, villous atrophy, and increased intraepithelial CD8+ T lymphocytes. It is diagnosed by serologic tests and confirmed with a duodenal biopsy. Treatment includes a strict gluten-free diet.</span></span></span></p>",
    "correct_choice_id": 41483,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10323,
    "choices": [
      {
        "id": 41258,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Single positive blood culture for HACK group is a major criterion</span></span></span></p>"
      },
      {
        "id": 41259,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Single positive blood culture for Coxiella Burnetti is a major criterion</span></span></span></p>"
      },
      {
        "id": 41260,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Complete dehiscence of prosthetic valve</span></span></span></p>"
      },
      {
        "id": 41261,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Documentation of four minor criterion allows a clinical diagnosis</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is true regarding the modified Duke&#39;s criteria: (NEET PG 2019)</span></span></p>",
    "unique_key": "Q3902401",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676650,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Single positive blood culture for Coxiella Burnetti is a major criterion </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Single positive blood culture for Coxiella Burnetti is considered as one of the major criteria to establish the diagnosis of infective endocarditis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/modified-duke-criteria-for-the-diagnostic-workup-of-infective-endocarditis.jpg\" style=\"height:1308px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Single positive blood culture for HACK group is a major criterion:</span></strong><span style=\"font-size:12.0pt\"> Incorrect terminology; it should refer to the HACEK group, and typically more than one positive blood culture is required unless other major criteria are also met.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Complete dehiscence of prosthetic valve:</span></strong><span style=\"font-size:12.0pt\"> This would provide imaging evidence of endocardial involvement and thus falls under a major criterion if detected via appropriate imaging but is not accurately captured in this statement.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Documentation of four minor criterion allows a clinical diagnosis:</span></strong><span style=\"font-size:12.0pt\"> According to the Modified Duke&rsquo;s Criteria, at least five minor criteria are needed to conclude infective endocarditis if no major criteria are met.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The detection of C. Burnetti in a single blood culture is a major criterion for the diagnosis of infective endocarditis due to the organism&#39;s strong association with this disease, despite being difficult to culture.</span></span></span></p>",
    "correct_choice_id": 41259,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "DiagnosisBased",
      "OlderNEETPG"
    ]
  },
  {
    "id": 9839,
    "choices": [
      {
        "id": 39323,
        "text": "<p><span style=\"font-size:12.0pt;\">Natural Killer cell lymphoblastic leukemia/lymphoma</span></p>"
      },
      {
        "id": 39324,
        "text": "<p><span style=\"font-size:12.0pt;\">B-lymphoblastic leukemia/lymphoma with hypodiploidy</span></p>"
      },
      {
        "id": 39325,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute myeloid leukemia with RUNX1 mutation</span></p>"
      },
      {
        "id": 39326,
        "text": "<p><span style=\"font-size:12.0pt;\">Splenic B-cell lymphoma/leukemia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">All leukemias come under provisional entity in WHO 2016 classification of hematolymphoid tumours except: </span>(AIIMS MAY 2018)</p>",
    "unique_key": "Q4027933",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676662,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) B-lymphoblastic leukemia/ lymphoma with hypodiploidy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>It is not a provisional entity under WHO 2016 Classification of Hematopoietic and Lymphoid Tumors</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Leukemias that come under provisional entity in WHO 2016 classification of hematolymphoid are:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Myeloid/lymphoid neoplasms with <strong>PCM1-JAK2</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Refractory cytopenia</strong> of childhood</span></li><li><span style=\"font-size:12.0pt;\">AML with <strong>BCR-ABL1</strong></span></li><li><span style=\"font-size:12.0pt;\">AML with mutated <strong>RUNX1 </strong>(Option C)</span></li><li><span style=\"font-size:12.0pt;\">B-lymphoblastic leukemia/lymphoma, <strong>BCR-ABL1\u2013like</strong></span></li><li><span style=\"font-size:12.0pt;\">B-lymphoblastic leukemia/lymphoma with <strong>iAMP21</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Early T-cell precursor</strong> lymphoblastic leukemia</span></li><li><span style=\"font-size:12.0pt;\">Natural killer (<strong>NK) cell</strong> lymphoblastic leukemia/lymphoma (Option A)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Splenic B-cell lymphoma/leukemia</strong>, unclassifiable (Option D)</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The WHO 2016 classification introduced several provisional entities in hematolymphoid neoplasms, which are conditions that are newly recognized or still under study for their clinical significance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>B-lymphoblastic leukemia/lymphoma with hypodiploidy</strong> is <strong>not a provisional entity</strong> under the WHO 2016 Classification of Hematopoietic and Lymphoid Tumors.</span></p>",
    "correct_choice_id": 39324,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 9828,
    "choices": [
      {
        "id": 39279,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Endothelial injury of vessel due to HTN</span></span></span></p>"
      },
      {
        "id": 39280,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Arterial internal elastic lamina defect</span></span></span></p>"
      },
      {
        "id": 39281,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Endothelial layer defect</span></span></span></p>"
      },
      {
        "id": 39282,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Adventitia defect</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Berry aneurysm occurs due to? (AIIMS NOV 2019)</span></span></p>",
    "unique_key": "Q3927714",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676658,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Ans. B) Arterial internal elastic lamina defect</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Berry aneurysm occurs due an <strong>arterial internal elastic lamina defect</strong>.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Berry (Saccular) aneurysms occur when <strong>there is collagen deficiency in the internal elastic lamina and breakdown of the tunica media.</strong> An outpouching, consisting of only tunica intima and adventitia, protrudes through the defect in the internal elastic lamina and tunica media to produce the aneurismal sac</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">As an aneurysm develops, it typically forms a neck with a dome and the arterial internal elastic lamina disappears at the base of the neck. The media thins and connective tissue replaces the smooth-muscle cells. The site of rupture is most often the dome. Here the wall thins, and the tear that allows bleeding is usually &le;0.5 mm long.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The most frequent cause of clinically significant subarachnoid hemorrhage is rupture of a saccular (berry) aneurysm.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Saccular/ Berry aneurysm is the most common type of intracranial aneurysm. About 90% of saccular aneurysms are found near major arterial branch points in the <strong>anterior circulation.</strong></span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Endothelial injury of vessel due to HTN:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While hypertension (HTN) is a risk factor that can exacerbate the progression of an aneurysm, it is not the primary cause of Berry aneurysm formation. The initial defect occurs in the internal elastic lamina.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Endothelial layer defect:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The endothelial layer is the innermost lining of blood vessels, but defects in this layer alone do not cause Berry aneurysms. The structural weakness in Berry aneurysms is primarily related to the internal elastic lamina and the underlying media.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D. Adventitia defect:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The adventitia is the outermost layer of the blood vessel, but defects in the adventitia alone are not responsible for the formation of Berry aneurysms. The crucial defect is in the internal elastic lamina.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Berry aneurysms&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">occur due to a defect in the <strong>arterial internal elastic lamina</strong>, leading to a weakened vessel wall and the potential for aneurysmal outpouching and rupture.</span></span></span></p>",
    "correct_choice_id": 39280,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 10111,
    "choices": [
      {
        "id": 40410,
        "text": "<p><span style=\"font-size:12.0pt;\">1+</span></p>"
      },
      {
        "id": 40411,
        "text": "<p><span style=\"font-size:12.0pt;\">2+</span></p>"
      },
      {
        "id": 40412,
        "text": "<p><span style=\"font-size:12.0pt;\">3+</span></p>"
      },
      {
        "id": 40413,
        "text": "<p><span style=\"font-size:12.0pt;\">Gene Amplification is done irrespective of Her 2 Neu status</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">In breast cancer, FISH for gene amplification will be done based on which of the following IHC staining for Her-2/neu?&nbsp;</span>(AIIMS MAY 2017)</p>",
    "unique_key": "Q2405330",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676671,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 2+</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the context of breast cancer, the <strong>Her-2/neu</strong> status is typically assessed by <strong>Immunohistochemistry (IHC)</strong>. The Her-2/neu protein overexpression is graded on a scale of 0 to 3+ based on the intensity and completeness of membrane staining. This grading is crucial in guiding further testing and treatment decisions.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>IHC 0 or 1+</strong>: These scores indicate no or low levels of Her-2/neu expression, respectively. Tumors with these scores are considered Her-2 negative, and no further testing for gene amplification is typically needed.</span></li><li><span style=\"font-size:12.0pt;\"><strong>IHC 2+</strong>: This score is considered <strong>equivocal</strong>. When a tumor shows a 2+ result on IHC, it suggests an intermediate level of Her-2/neu expression. Because this result is not definitively positive or negative, <strong>Fluorescence in Situ Hybridization (FISH)</strong> testing is recommended to assess for <strong>gene amplification</strong> of Her-2/neu. FISH is a more sensitive and specific test that directly detects the amplification of the Her-2/neu gene, providing definitive information about the tumor's status.</span></li><li><span style=\"font-size:12.0pt;\"><strong>IHC 3+</strong>: A score of 3+ indicates a high level of Her-2/neu protein overexpression. Tumors with this score are considered <strong>Her-2 positive</strong> and typically do not require further FISH testing, as the overexpression is sufficient to warrant Herceptin (trastuzumab) therapy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Herceptin</strong> is a targeted therapy that specifically inhibits the Her-2/neu receptor, which is overexpressed in some breast cancers, leading to more aggressive tumor behavior. Therefore, determining the correct Her-2/neu status through IHC and, if necessary, confirming with FISH is crucial in selecting the appropriate treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 1+:</strong> IHC 1+ is considered Her-2/neu negative, and FISH testing is generally not indicated in these cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 3+:</strong> IHC 3+ is strongly positive for Her-2/neu, making FISH testing unnecessary since the high expression level is sufficient to guide treatment decisions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Gene Amplification is done irrespective of Her 2 Neu status:</strong> This option is incorrect because FISH testing for gene amplification is specifically indicated in cases with an equivocal IHC result (2+), not irrespective of Her-2/neu status.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">FISH for Her-2/neu gene amplification is performed when the IHC result is 2+, as this score is considered equivocal, requiring further testing to determine the appropriate therapeutic approach.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-367.jpg\" alt=\"\" width=\"500\" height=\"791\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/42.jpg\" alt=\"\" width=\"406\" height=\"445\"></span></p>",
    "correct_choice_id": 40411,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "CriteriaBased",
      "InvestigationBased"
    ]
  },
  {
    "id": 65282,
    "choices": [
      {
        "id": 260301,
        "text": "<p><span style=\"font-size:12.0pt;\">Folate deficiency</span></p>"
      },
      {
        "id": 260302,
        "text": "<p><span style=\"font-size:12.0pt;\">Pernicious anemia with Vitamin B12 deficiency</span></p>"
      },
      {
        "id": 260303,
        "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency anemia</span></p>"
      },
      {
        "id": 260304,
        "text": "<p><span style=\"font-size:12.0pt;\">Sideroblastic anemia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 34-year-old female presents with chronic fatigue, glossitis, and a tingling sensation in her hands and feet. A peripheral blood smear reveals macrocytic red blood cells and hypersegmented neutrophils. Endoscopy reveals atrophic gastritis. Which of the following conditions is likely to be seen in this patient? (Twisted PYQ)</span></p>",
    "unique_key": "Q1131782",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676614,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Pernicious anemia with Vitamin B12 deficiency</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The presentation of chronic fatigue, glossitis, and neuropathy (tingling sensations) alongside findings of macrocytosis and hypersegmented neutrophils on a peripheral smear strongly suggests <strong>pernicious anemia</strong>, a form of <strong>Vitamin B12 deficiency</strong>. The atrophic gastritis observed on endoscopy supports an autoimmune etiology, where intrinsic factor production is impaired, leading to malabsorption of Vitamin B12. The neurological symptoms, which are unique to Vitamin B12 deficiency, further confirm this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong> Folate deficiency also causes macrocytosis and hypersegmented neutrophils but does not typically lead to neurological symptoms or atrophic gastritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong> Iron deficiency anemia results in microcytic, hypochromic anemia and is not associated with macrocytosis or hypersegmented neutrophils.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> Sideroblastic anemia causes microcytic anemia and is linked to defective hemoglobin synthesis, not the findings described here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Pernicious anemia, an autoimmune condition impairing Vitamin B12 absorption, presents with macrocytic anemia, hypersegmented neutrophils, and neurological symptoms. It is associated with atrophic gastritis and requires prompt recognition and treatment to prevent irreversible neurological damage.</span></p>",
    "correct_choice_id": 260302,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 10286,
    "choices": [
      {
        "id": 41110,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chromosome 19</span></span></span></p>"
      },
      {
        "id": 41111,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chromosome 20</span></span></span></p>"
      },
      {
        "id": 41112,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chromosome 21</span></span></span></p>"
      },
      {
        "id": 41113,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chromosome 22</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which chromosome is involved in myotonic dystrophy? (NEET PG 2018)</span></span></span></p>",
    "unique_key": "Q5751614",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676629,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Chromosome 19</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Myotonic dystrophy is an inherited genetic disorder that affects muscle function. It is caused by an abnormal expansion of nucleotide repeats in the DMPK gene on chromosome 19.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Myotonic dystrophy (DM) is a type of muscular dystrophy, a group of genetic disorders that cause progressive muscle loss and weakness. In DM, muscles are often unable to relax after contraction. Other manifestations may include cataracts, intellectual disability and heart conduction problems. In men, there may be early balding and an inability to father children. While myotonic dystrophy can occur at any age, onset is typically in the 20s and 30s.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">There is no cure. Treatments may include braces or wheelchairs, pacemakers and non-invasive positive pressure ventilation. The medications mexiletine or carbamazepine can help relax muscles. Pain, if it occurs, may be treated with tricyclic antidepressants and nonsteroidal anti-inflammatory drugs (NSAIDs).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Chromosome 20, Option C. Chromosome 21&nbsp;</span></strong><span style=\"font-size:12.0pt\">and<strong> Option D. Chromosome 22</strong>: These chromosomes are not associated with the mutation causing myotonic dystrophy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Myotonic dystrophy is linked to a mutation in the DMPK gene on chromosome 19, leading to diverse symptoms including muscle dysfunction, cataracts, and cardiac issues.</span></span></span></p>",
    "correct_choice_id": 41110,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 10436,
    "choices": [
      {
        "id": 41710,
        "text": "<p><span style=\"font-size:12.0pt;\">Aortic dissection</span></p>"
      },
      {
        "id": 41711,
        "text": "<p><span style=\"font-size:12.0pt;\">Subluxation of lens</span></p>"
      },
      {
        "id": 41712,
        "text": "<p><span style=\"font-size:12.0pt;\">Mitral valve prolapse</span></p>"
      },
      {
        "id": 41713,
        "text": "<p><span style=\"font-size:12.0pt;\">Bilateral small streak ovaries</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The mother of a 12-year-old girl was worried that her daughter is shorter when compared with her classmates. On examination, the child had a webbed neck, low hairline, and shield chest. A provisional diagnosis of Turner's syndrome was made. Which of the following is a likely finding to be seen in this patient? (NEET PG 2021)</span></p>",
    "unique_key": "Q4463373",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676642,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Bilateral small streak ovaries</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The likely finding seen in a patient with Turner syndrome is bilateral small streak ovaries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Turner syndrome results from complete or partial monosomy of the X chromosome. It is characterized by hypogonadism in phenotypic females. It is the most common sex chromosome abnormality in females. Three types of karyotypic abnormalities are seen</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Missing an entire X chromosome - this results in a 45X0 karyotype.</span></li><li><span style=\"font-size:12.0pt;\">Structural abnormalities of the X chromosomes</span></li><li><span style=\"font-size:12.0pt;\">Mosaics - they will have 45X along with one or more karyotypically normal or abnormal cell types. Examples are 45X/46XX, 45X/46XY, 45X/47XXX, 45\u00d7/46X, \u00a1(X)(q10).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Important features associated with Turner's syndrome:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/11/untitled-26.jpg\" alt=\"\" width=\"269\" height=\"381\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Short stature</span></li><li><span style=\"font-size:12.0pt;\">Webbing of neck</span></li><li><span style=\"font-size:12.0pt;\">Broad chest and widely spaced nipples</span></li><li><span style=\"font-size:12.0pt;\">Cubitus valgus</span></li><li><span style=\"font-size:12.0pt;\">Streak ovaries</span></li><li><span style=\"font-size:12.0pt;\">Infertility, amenorrhea</span></li><li><span style=\"font-size:12.0pt;\">Peripheral lymphedema at birth</span></li><li><span style=\"font-size:12.0pt;\">Low posterior hairline</span></li><li><span style=\"font-size:12.0pt;\">Broad chest and widely spaced nipples</span></li><li><span style=\"font-size:12.0pt;\">Pigmented nevi</span></li><li><span style=\"font-size:12.0pt;\">Coarctation of aorta</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Normal secondary sex characteristics do not develop during puberty. The genitalia remain infantile, breast development is inadequate, and pubic hair is scarce. In adults, short stature and amenorrhea are especially important in establishing the diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aortic dissection: </strong>While Turner syndrome is associated with cardiovascular abnormalities, such as coarctation of the aorta and bicuspid aortic valve, aortic dissection is less common in children and typically occurs in adults with significant aortic disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Subluxation of lens:</strong> Subluxation of the lens is a feature of Marfan syndrome, not Turner syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mitral valve prolapse:</strong> Mitral valve prolapse is more commonly associated with connective tissue disorders like Marfan syndrome and Ehlers-Danlos syndrome. Turner syndrome is more characteristically associated with left-sided heart defects like coarctation of the aorta.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Turner syndrome is characterized by features such as short stature, webbed neck, shield chest, and streak ovaries, leading to primary ovarian insufficiency, infertility, and amenorrhea. The diagnosis is confirmed by karyotyping, and the most likely finding in Turner syndrome patients is bilateral small streak ovaries.</span></p>",
    "correct_choice_id": 41713,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 65280,
    "choices": [
      {
        "id": 260293,
        "text": "<p><span style=\"font-size:12.0pt;\">Infective endocarditis on a rheumatic valve</span></p>"
      },
      {
        "id": 260294,
        "text": "<p><span style=\"font-size:12.0pt;\">Calcification and fibrosis of Mitral Valve</span></p>"
      },
      {
        "id": 260295,
        "text": "<p><span style=\"font-size:12.0pt;\">Rupture of chordae tendineae</span></p>"
      },
      {
        "id": 260296,
        "text": "<p><span style=\"font-size:12.0pt;\">Hypertrophy of the left atrial wall</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old male with a history of chronic atrial fibrillation and previous rheumatic fever presents with severe fatigue and palpitations. He dies suddenly, and autopsy findings reveal a mitral valve with a \"fish mouth\" appearance and superimposed vegetations. What is the most likely cause of death in this patient? (Twisted PYQ)</span></p>",
    "unique_key": "Q5506601",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676612,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Infective endocarditis on a rheumatic valve</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The \"fish mouth\" or \"buttonhole\" appearance of the mitral valve is characteristic of chronic rheumatic heart disease, marked by calcification, fibrosis, and commissural fusion. The presence of superimposed vegetations on autopsy indicates infective endocarditis. Rheumatic valves, due to their deformed structure and altered blood flow dynamics, are predisposed to infection, leading to infective endocarditis. This condition is often fatal if left untreated, particularly in patients with underlying cardiac abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>: While calcification and fibrosis are the primary changes in rheumatic heart disease, they do not explain the presence of vegetations in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>: Rupture of chordae tendineae is seen in acute mitral regurgitation but is not related to the findings of vegetations and stenosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>: Hypertrophy of the left atrial wall occurs as a secondary change due to chronic pressure overload in mitral stenosis but is not the cause of sudden death in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with chronic rheumatic heart disease, deformed valves are at high risk for developing infective endocarditis, particularly in the setting of atrial fibrillation or other contributing factors. Recognizing this complication is critical for timely intervention and management.</span></p>",
    "correct_choice_id": 260293,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 65279,
    "choices": [
      {
        "id": 260289,
        "text": "<p><span style=\"font-size:12.0pt;\">Alpha chain disease</span></p>"
      },
      {
        "id": 260290,
        "text": "<p><span style=\"font-size:12.0pt;\">Gamma chain disease</span></p>"
      },
      {
        "id": 260291,
        "text": "<p><span style=\"font-size:12.0pt;\">Mu chain disease</span></p>"
      },
      {
        "id": 260292,
        "text": "<p><span style=\"font-size:12.0pt;\">Delta chain disease</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which form of heavy chain disease is most commonly associated with systemic lymphadenopathy and hepatosplenomegaly? (Twisted PYQ)</span></p>",
    "unique_key": "Q4354499",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676665,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Gamma chain disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Gamma chain disease is a rare form of heavy chain disease characterized by the production of abnormal gamma heavy chains (from immunoglobulin G, IgG). It often presents with systemic lymphadenopathy, hepatosplenomegaly, and, in some cases, symptoms of immunodeficiency. Unlike alpha chain disease, which primarily affects the intestinal mucosa, gamma chain disease is more systemic in nature, with lymphoproliferative involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong> Alpha chain disease is the most prevalent form of heavy chain disease but is primarily associated with gastrointestinal symptoms due to mucosal infiltration in the small intestine, not systemic lymphadenopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong> Mu chain disease is exceedingly rare and often presents with features similar to chronic lymphocytic leukemia or lymphoplasmacytic lymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> Delta chain disease, involving IgD heavy chains, is extremely rare and does not typically present with systemic lymphadenopathy and hepatosplenomegaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Gamma chain disease is a rare lymphoproliferative disorder associated with systemic manifestations such as lymphadenopathy, hepatosplenomegaly, and potential immunodeficiency. It is distinct from other heavy chain diseases that may have more localized presentations.</span></p>",
    "correct_choice_id": 260290,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 10065,
    "choices": [
      {
        "id": 40226,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1, 2, 4</span></span></span></p>"
      },
      {
        "id": 40227,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2, 3</span></span></span></p>"
      },
      {
        "id": 40228,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1, 3</span></span></span></p>"
      },
      {
        "id": 40229,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1, 4</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following statements is true regarding clear cell carcinoma of the kidney?</span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">(INICET MAY 2022) </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is the most common sporadic renal tumor</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Associated with loss of long arm of chromosome 3</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Arises from distal convoluted tubule</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cells show intracellular accumulation of glycogen and fat</span></span></span></li>\r\n</ol>",
    "unique_key": "Q1468201",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676649,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>D) 1, 4 </strong>&nbsp;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CLEAR CELL CARCINOMA</span></u></strong><strong> </strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">(Most Common variant)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mutation -&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">VHL gene (Occasionally associated with von Hippel-Lindau syndrome). Associated with loss of short arm of chromosome 3.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Arise most likely from proximal tubular epithelium, and usually occur as solitary unilateral lesions.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Radiographic findings -&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypervascular mass with homogeneous enhancement</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gross:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Solid mass with a golden-yellow appearance</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Histopathology -&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clear cytoplasm due to washing of accumulated glycogen and lipid droplets. Prominent vasculature and sheets of polygonal cells.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Statement 2</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Associated with loss of short arm of chromosome 3, not long.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Statement 3</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Arise most likely from proximal tubular epithelium, not distal.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/2.jpg\" style=\"height:308px; width:462px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clear cell carcinoma of the kidney is the most common sporadic renal tumor and is characterized by cells with intracellular accumulation of glycogen and fat, as well as an association with the loss of the short arm of chromosome 3.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins pathologic basis of disease 8<sup>th</sup> edition pg 1847-1849</span></strong></span></span></p>",
    "correct_choice_id": 40229,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 10494,
    "choices": [
      {
        "id": 41942,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Non-Hodgkin&#39;s lymphoma, RS cell, EBV</span></span></span></p>"
      },
      {
        "id": 41943,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Kaposi sarcoma, Giant cell, HIV</span></span></span></p>"
      },
      {
        "id": 41944,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hodgkin&#39;s lymphoma, RS cell, EBV</span></span></span></p>"
      },
      {
        "id": 41945,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Infectious mononucleosis, RS cell, CMV</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 6-year-old boy came with bilateral cervical lymphadenopathy. What is the probable diagnosis, cell, and virus associated with the image given below? (</span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AIIMS&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">NOV 2021)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">(</span><span style=\"font-size:12.0pt\">RS cell: Reed - Sternberg cell, HIV: Human immunodeficiency virus, CMV: Cytomegalovirus, EBV: Epstein-Barr virus</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-398.jpg\" style=\"height:246px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q6623810",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676670,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Hodgkin&#39;s lymphoma, RS cell, EBV</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The probable diagnosis, cell, and virus from the given clinical scenario and the histopathological image are Hodgkin&#39;s lymphoma, Reed-Sternberg cells (RS cells), and Epstein-Barr virus (EBV) respectively.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Identification of Reed-Sternberg cells and their variants is essential for the diagnosis of Hodgkin&rsquo;s lymphoma. Diagnostic Reed-Sternberg cells are large cells (&ge;45 &mu;m in diameter) with multiple nuclei or a single nucleus with multiple nuclear lobes, each with a large inclusion-like nucleolus about the size of a small lymphocyte (5&ndash;7 &mu;m in diameter).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-04-181612.png\" style=\"height:642px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Non-Hodgkin&#39;s lymphoma, RS cell, EBV</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Non-Hodgkin&#39;s lymphoma does not typically feature Reed-Sternberg cells. While EBV can be associated with some types of Non-Hodgkin&#39;s lymphoma, the presence of RS cells is specific to Hodgkin&#39;s lymphoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Kaposi sarcoma, Giant cell, HIV</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Kaposi sarcoma is associated with human herpesvirus 8 (HHV-8) and often presents with spindle cells and slit-like vascular spaces, not Reed-Sternberg cells. It is more commonly associated with HIV.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Infectious mononucleosis, RS cell, CMV</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Infectious mononucleosis is usually associated with EBV, not CMV, and while it can cause atypical lymphocytosis, it does not produce Reed-Sternberg cells, which are specific to Hodgkin&#39;s lymphoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hodgkin&#39;s lymphoma&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is characterized by the presence of <strong>Reed-Sternberg (RS) cells</strong>, and it is often associated with <strong>Epstein-Barr virus (EBV)</strong>, particularly in specific subtypes.</span></span></span></p>",
    "correct_choice_id": 41944,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 50666,
    "choices": [
      {
        "id": 202202,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti-nuclear antibody</span></p>"
      },
      {
        "id": 202203,
        "text": "<p><span style=\"font-size:12.0pt;\">SCL-70 antibody</span></p>"
      },
      {
        "id": 202204,
        "text": "<p><span style=\"font-size:12.0pt;\">U1-RNP antibody</span></p>"
      },
      {
        "id": 202205,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti-CCP antibody</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following antibodies is diagnostic for mixed connective tissue disease? (NEET PG 2016)</span></p>",
    "unique_key": "Q2811106",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676659,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Correct Answer: C. U1-RNP antibody</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mixed connective tissue disease is characterized by high titers of antibodies to U1 ribonucleoprotein (U1-RNP). This antibody is considered diagnostic for the condition, which presents with clinical features that overlap with those of SLE, systemic sclerosis, and polymyositis. Patients typically present with synovitis of the fingers, Raynaud phenomenon, myositis, and renal involvement, which usually responds well to corticosteroids, at least in the short term.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Anti-nuclear antibody</strong> - While anti-nuclear antibodies (ANAs) are present in mixed connective tissue disease, they are not specific for this condition. ANAs are found in many autoimmune diseases including SLE, systemic sclerosis, and Sj\u00f6gren syndrome, so their presence alone cannot differentiate mixed connective tissue disease from other connective tissue disorders.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. SCL-70 antibody</strong> - SCL-70 antibody (anti-DNA topoisomerase I) is associated with systemic sclerosis (scleroderma), particularly the diffuse cutaneous form with increased risk of pulmonary fibrosis and peripheral vascular disease. It is not characteristic of mixed connective tissue disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Anti-CCP antibody</strong> - Anti-cyclic citrullinated peptide (anti-CCP) antibodies are highly specific for rheumatoid arthritis. They are not typically found in mixed connective tissue disease and are used to differentiate rheumatoid arthritis from other forms of inflammatory arthritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">High titres of antibodies to U1 ribonucleoprotein (U1-RNP) are the serological hallmark and diagnostic marker for mixed connective tissue disease, a condition with overlapping features of several autoimmune disorders including SLE, systemic sclerosis, and polymyositis.</span></p>",
    "correct_choice_id": 202204,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "OlderNEETPG"
    ]
  },
  {
    "id": 54944,
    "choices": [
      {
        "id": 219237,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Whipple disease</span></span></span></p>"
      },
      {
        "id": 219238,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Celiac disease</span></span></span></p>"
      },
      {
        "id": 219239,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Crohn disease</span></span></span></p>"
      },
      {
        "id": 219240,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lactose intolerance</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient with chronic diarrhea develops dermatitis herpetiformis. The physician altered his diet which improved his symptoms. Which of the following is the likely diagnosis? (FMGE JULY 2024)</span></span></span></p>",
    "unique_key": "Q8607533",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676625,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B) Celiac disease</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Celiac disease is an autoimmune disorder in which the ingestion of gluten leads to damage in the small intestine. The immune system mistakenly targets gluten, along with the lining of the small intestine, leading to symptoms such as chronic diarrhea, malabsorption, and weight loss. One of the hallmark dermatological manifestations of celiac disease is dermatitis herpetiformis. This condition presents as a chronic, intensely itchy rash, typically on the elbows, knees, back, and buttocks, and is caused by <strong>the deposition of IgA antibodies</strong> <strong>at the dermoepidermal junction</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The improvement of symptoms following the alteration of the <strong>patient&rsquo;s diet to exclude gluten is a classic indicator of celiac disease. </strong>Once gluten is removed from the diet, the intestinal inflammation subsides, and symptoms, including dermatitis herpetiformis, typically improve.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Whipple disease:</span></strong><span style=\"font-size:12.0pt\"> Whipple disease is a <strong>rare bacterial infection</strong> that can cause malabsorption, leading to symptoms such as diarrhea and weight loss. However, it does not typically cause dermatitis herpetiformis, nor does dietary modification alone usually lead to symptom improvement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Crohn disease:</span></strong><span style=\"font-size:12.0pt\"> Crohn&#39;s disease is an inflammatory bowel disease that can cause chronic diarrhea, abdominal pain, and malabsorption. However, it does not cause dermatitis herpetiformis, and dietary changes like removing gluten do not usually lead to the dramatic improvement seen in celiac disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Lactose intolerance:</span></strong><span style=\"font-size:12.0pt\"> Lactose intolerance results from the inability to digest lactose, leading to gastrointestinal symptoms like bloating, diarrhea, and abdominal pain after consuming dairy products. It does not cause dermatitis herpetiformis, and the improvement in symptoms would be related to avoiding dairy, not gluten.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Celiac disease should be suspected in patients presenting with chronic diarrhea and dermatitis herpetiformis, particularly when symptoms improve following a gluten-free diet.</span></span></span></p>",
    "correct_choice_id": 219238,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE"
    ]
  },
  {
    "id": 54506,
    "choices": [
      {
        "id": 217493,
        "text": "<p><span style=\"font-size:12.0pt;\">Chronic venous insufficiency</span></p>"
      },
      {
        "id": 217494,
        "text": "<p><span style=\"font-size:12.0pt;\">Chronic renal failure</span></p>"
      },
      {
        "id": 217495,
        "text": "<p><span style=\"font-size:12.0pt;\">Congestive heart failure</span></p>"
      },
      {
        "id": 217496,
        "text": "<p><span style=\"font-size:12.0pt;\">Chronic liver disease</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Bilateral pedal edema is least likely to be associated with which of the following?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q2216882",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676661,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Chronic venous insufficiency</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bilateral pedal edema is often due to systemic conditions that lead to fluid retention or increased pressure in the veins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Chronic venous insufficiency</strong>, typically results from conditions like deep vein thrombosis (DVT), which is more likely to cause unilateral (one-sided) pedal edema due to localized obstruction of venous return. While chronic venous insufficiency can sometimes cause bilateral edema, it is less common compared to the other conditions listed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Chronic renal failure:</strong> Patients with chronic renal failure cannot excrete excess fluid properly, leading to fluid retention and generalized edema, including in both legs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Congestive heart failure:</strong> Heart failure results in increased venous pressure and fluid retention, which typically causes dependent edema, including bilateral pedal edema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chronic liver disease:</strong> Liver disease can lead to hypoalbuminemia and reduced oncotic pressure, causing generalized and bilateral pedal edema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic venous insufficiency is least likely to be associated with bilateral pedal edema compared to chronic renal failure, congestive heart failure, and chronic liver disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Edema results from imbalances in:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>Hydrostatic pressure</strong> (\u2191 in heart failure)</span></li><li><span style=\"font-size:16px;\"><strong>Oncotic pressure</strong> (\u2193 in liver/kidney disease)</span></li><li><span style=\"font-size:16px;\"><strong>Lymphatic drainage</strong></span></li><li><span style=\"font-size:16px;\"><strong>Capillary permeability</strong></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\">Summary Table:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_6PG9POy.png\" width=\"1116\" height=\"361\"></span></p>",
    "correct_choice_id": 217493,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 32308,
    "choices": [
      {
        "id": 129090,
        "text": "<p><span style=\"font-size:12.0pt;\">Iron</span></p>"
      },
      {
        "id": 129091,
        "text": "<p><span style=\"font-size:12.0pt;\">Magnesium</span></p>"
      },
      {
        "id": 129092,
        "text": "<p><span style=\"font-size:12.0pt;\">Zinc</span></p>"
      },
      {
        "id": 129093,
        "text": "<p><span style=\"font-size:12.0pt;\">Manganese</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Deficiency of which of the following nutrients can lead to delayed wound healing? (FMGE JULY 2023)</span></p>",
    "unique_key": "Q8268356",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676634,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Zinc</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Zinc is an essential mineral that plays a crucial role in various physiological processes, including DNA synthesis, cell division, and protein synthesis, all of which are vital for wound healing. Zinc is a cofactor for numerous enzymes, including matrix metalloproteinases, which are involved in the remodeling of extracellular matrix during wound healing. A deficiency in zinc impairs these processes, leading to delayed wound healing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Iron</strong>: Iron is important for oxygen transport and cellular respiration, but its deficiency primarily leads to anemia and fatigue rather than directly causing delayed wound healing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Magnesium</strong>: Magnesium is involved in many biochemical reactions, but its deficiency is more likely to cause muscle cramps, arrhythmias, and neuromuscular issues rather than significantly impacting wound healing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Manganese</strong>: Manganese is a trace mineral important for bone formation and metabolism. While it is involved in enzyme function, its deficiency is less commonly linked to delayed wound healing compared to zinc.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Zinc is required for functioning of matrix metalloproteases and so, required for proper wound healing. Any deficiency of zinc can lead to delayed wound healing.</span></p>",
    "correct_choice_id": 129092,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 31891,
    "choices": [
      {
        "id": 127434,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Target cell</span></span></span></p>"
      },
      {
        "id": 127435,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hairy cell </span></span></span></p>"
      },
      {
        "id": 127436,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gaucher cell </span></span></span></p>"
      },
      {
        "id": 127437,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sickle cell</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Below is an electron microscopy depiction of a cellular structure. Determine the type of cell being depicted. (NEET PG 2023)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/screenshot-2023-12-30-194200.jpg\" style=\"height:268px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q6520574",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676620,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Hairy cell </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hairy cells are seen in Hairy cell leukemia. It is a B-cell tumor. Peripheral smear shows pancytopenia; hairy cells. Flow cytometry shows CD11/25/103 + cells. Annexin &ndash;A is the best marker.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Target cell:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> can be seen in&nbsp;thalassemia, hepatic disease with jaundice, hemoglobin C disorders, and the post splenectomy state.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/screenshot-2023-12-30-194237.jpg\" style=\"height:216px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.</span></strong> <strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gaucher cell:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is found in Gaucher&rsquo;s disease which occurs due to absence of beta glucocerebrosidase enzyme.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/screenshot-2023-12-30-194314.jpg\" style=\"height:222px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D.</span></strong> <strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sickle cells: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;are seen in sickle cell anemia. HbS has altered solubility and high chance of polymer formation especially with dehydration</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> or hypoxemia causing alteration in shape. On rehydration, it is reversible.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hairy cells are seen in hairy cell leukemia, characterized by B lymphocytes with hair-like projections, and are identified using electron microscopy and specific markers like CD11c, CD25, CD103, and Annexin-A.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/screenshot-2023-12-30-194348.jpg\" style=\"height:240px; width:300px\" /></span></span></span></p>",
    "correct_choice_id": 127435,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 54507,
    "choices": [
      {
        "id": 217497,
        "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
      },
      {
        "id": 217498,
        "text": "<p><span style=\"font-size:12.0pt;\">1,2 and 3</span></p>"
      },
      {
        "id": 217499,
        "text": "<p><span style=\"font-size:12.0pt;\">1,3 and 4</span></p>"
      },
      {
        "id": 217500,
        "text": "<p><span style=\"font-size:12.0pt;\">1,2,3,4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a feature of delayed blood transfusion reaction?&nbsp;</span>&nbsp;(INICET MAY 2024)</p><ol><li><span style=\"font-size:12.0pt;\">Increased unconjugated bilirubin</span></li><li><span style=\"font-size:12.0pt;\">Cola colored urine after 2 hours</span></li><li><span style=\"font-size:12.0pt;\">Increased LDH</span></li><li><span style=\"font-size:12.0pt;\">Failure of rise of hemoglobin after transfusion</span></li></ol>",
    "unique_key": "Q6089513",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676660,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 1, 3 and 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Delayed blood transfusion reactions typically occur more than 24 hours after the initiation of a blood transfusion. These reactions can result from various immune-mediated processes, often involving the destruction of transfused red blood cells. The features of delayed blood transfusion reactions include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Increased unconjugated bilirubin</strong>: This occurs due to hemolysis, where the breakdown of red blood cells releases hemoglobin that is converted into unconjugated bilirubin.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Increased LDH (Lactate Dehydrogenase)</strong>: LDH is an enzyme found in many tissues, including red blood cells. When red blood cells are destroyed, LDH levels in the blood increase.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Failure of rise of hemoglobin after transfusion</strong>: Despite the transfusion, the hemoglobin level does not increase as expected because the transfused red blood cells are being destroyed.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Incorrect Statement&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 2 Cola colored urine after 2 hours</strong>: Cola-colored urine shortly after transfusion is indicative of an acute hemolytic transfusion reaction, not a delayed reaction. Delayed hemolytic reactions typically present with cola-colored urine after several days, not within 2 hours.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Delayed blood transfusion reactions occur more than 24 hours after transfusion and are characterized by increased unconjugated bilirubin, increased LDH, and failure of hemoglobin levels to rise. Immediate cola-colored urine indicates an acute reaction, not a delayed one.</span></p>",
    "correct_choice_id": 217499,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 10109,
    "choices": [
      {
        "id": 40402,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 3</span></p>"
      },
      {
        "id": 40403,
        "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
      },
      {
        "id": 40404,
        "text": "<p><span style=\"font-size:12.0pt;\">2 and 3</span></p>"
      },
      {
        "id": 40405,
        "text": "<p><span style=\"font-size:12.0pt;\">1 and 3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient has a HbA2 of 3% and HbF of 97%. A peripheral blood smear is taken. Which of the following blood pictures will be seen in this patient? </span>(AIIMS MAY 2017)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/40.jpg\" alt=\"\" width=\"699\" height=\"228\"></p>",
    "unique_key": "Q2846170",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676631,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. </strong></span><span style=\"background-color:transparent;font-size:11pt;\"><strong>A) 1, 2 and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Based on the patient's HbA2 and HbF levels, this patient likely has beta thalassemia major, a condition where the body produces less than normal amounts of hemoglobin beta chains. This results in a decrease in HbA, and an increase in HbF and HbA2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Beta thalassemia will have high HbA2 levels (&gt;3.5%) and slightly increased HbF</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The peripheral blood smear of a patient with beta thalassemia major will show hypochromic microcytic red blood cells (Image 1), which are smaller and paler than normal. Howell-jolly bodies (image 2) will also be seen. These cells may also be more variable in size and shape, and may have a target cell appearance (Image 3) due to increased membrane-to-cytoplasm ratio.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Other possible findings on the blood smear may include anisocytosis (variation in cell size), poikilocytosis (variation in cell shape), and nucleated red blood cells (if the patient has severe anemia).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It's important to note that the blood smear alone is not sufficient to diagnose beta thalassemia major, and additional laboratory tests and genetic testing may be necessary for confirmation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Image 2 shows Howell\u2013Jolly bodies, which are small, round, dark purple inclusions within red blood cells (RBCs), representing residual nuclear DNA fragments. These inclusions are typically removed by a healthy spleen; their presence often indicates splenic dysfunction or absence.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Conditions Associated with Howell\u2013Jolly Bodies</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of Howell\u2013Jolly bodies is commonly associated with:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Post-splenectomy: Following surgical removal of the spleen</span></li><li><span style=\"font-size:12.0pt;\">Functional asplenia or hyposplenism: Conditions like sickle cell disease can lead to spleen dysfunction</span></li><li><span style=\"font-size:12.0pt;\">Megaloblastic anemia: Due to vitamin B12 or folate deficiency</span></li><li><span style=\"font-size:12.0pt;\">Severe hemolytic anemia: Where rapid RBC destruction overwhelms the spleen's filtering capacity</span></li><li><span style=\"font-size:12.0pt;\">Myelodysplastic syndromes: Bone marrow disorders affecting blood cell production</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In beta thalassemia major, the peripheral blood smear typically shows hypochromic microcytic red blood cells and target cells, which are best represented by Image 1 and Image 3.</span></p>",
    "correct_choice_id": 40402,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 10287,
    "choices": [
      {
        "id": 41114,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PTEN</span></span></span></p>"
      },
      {
        "id": 41115,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">WT1</span></span></span></p>"
      },
      {
        "id": 41116,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">p53</span></span></span></p>"
      },
      {
        "id": 41117,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ras</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cowden syndrome is associated with mutation in: (NEET PG 2018)</span></span></p>",
    "unique_key": "Q1542512",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676630,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) PTEN </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cowden syndrome is a genetic disorder characterized by multiple tumor-like growths and an increased risk of certain cancers. It is associated with mutations in the PTEN gene, a tumor suppressor gene. This mutation leads to dysregulated cell growth and survival, contributing to the development of benign and malignant tumors, particularly in the breast, thyroid, and endometrium.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. WT1</span></strong><span style=\"font-size:12.0pt\">: Associated with Wilms&#39; tumor.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. p53</span></strong><span style=\"font-size:12.0pt\">: Commonly mutated in various cancers but not specifically associated with Cowden syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Ras</span></strong><span style=\"font-size:12.0pt\">: Linked to a variety of cancers through different mechanisms but not directly to Cowden syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/screenshot-2023-12-30-134134.jpg\" style=\"height:726px; width:1000px\" /></p>",
    "correct_choice_id": 41114,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 65281,
    "choices": [
      {
        "id": 260297,
        "text": "<p><span style=\"font-size:12.0pt;\">Fibrillin</span></p>"
      },
      {
        "id": 260298,
        "text": "<p><span style=\"font-size:12.0pt;\">Type I Collagen</span></p>"
      },
      {
        "id": 260299,
        "text": "<p><span style=\"font-size:12.0pt;\">Elastase</span></p>"
      },
      {
        "id": 260300,
        "text": "<p><span style=\"font-size:12.0pt;\">Laminin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">An adult patient presents with short stature, blue sclerae, multiple fractures with minimal trauma, and hearing loss. This patient is likely to have a defect in which of the following? (Twisted PYQ)</span></p>",
    "unique_key": "Q8052313",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676613,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Type I Collagen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The clinical presentation of short stature, blue sclerae, recurrent fractures, and hearing loss is characteristic of <strong>osteogenesis imperfecta (OI)</strong>, a genetic disorder of connective tissue primarily caused by mutations in genes encoding Type I collagen (e.g., COL1A1 and COL1A2). Type I collagen is a critical structural protein in bones, skin, and other connective tissues. The defect results in brittle bones, increased fracture risk, and the hallmark blue sclera due to the translucency of the sclera allowing visualization of the underlying choroid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong> Fibrillin defects are associated with Marfan syndrome, which presents with tall stature, lens dislocation, and aortic aneurysms, not the features described here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong> Elastase abnormalities are linked to alpha-1 antitrypsin deficiency, causing emphysema and liver disease, not connective tissue fragility or fractures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> Laminin is involved in the structural integrity of tissues but is not related to the findings in osteogenesis imperfecta.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Osteogenesis imperfecta is a connective tissue disorder caused by defects in Type I collagen, leading to fragile bones, blue sclerae, and hearing loss. Early recognition is essential for managing fractures and improving the patient\u2019s quality of life.</span></p>",
    "correct_choice_id": 260298,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 10493,
    "choices": [
      {
        "id": 41938,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dark areas represent necrosis, white areas represent viable liver tissue</span></span></span></p>"
      },
      {
        "id": 41939,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dark areas represent viable liver tissue, white areas represent necrosis</span></span></span></p>"
      },
      {
        "id": 41940,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">White areas represent central hepatocytes</span></span></span></p>"
      },
      {
        "id": 41941,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dark areas represent peri-portal hepatocytes</span><strong>&nbsp;</strong></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with cirrhosis and ascites presented to you. The gross appearance of his liver is as shown below. Which among the following is true about it? (AIIMS NOV 2021)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-397.jpg\" style=\"height:202px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q9919889",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676669,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Dark areas represent necrosis; white areas represent viable liver tissue.</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The above picture shows centrilobular hemorrhagic necrosis. The cut liver section, in which major blood vessels are visible, is notable for a variegated, mottled, red appearance (nutmeg liver) seen in right heart failure. <strong>The dark areas represent necrosis; white areas represent viable liver tissue</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Nutmeg liver refers to the mottled appearance of the liver which resembles the cut section of nutmeg. This occurs as a result of hepatic venous congestion following right heart failure. The dark centrilobular zones reflect sinusoidal congestion<strong>. Congestion is seen around the central veins usually from right-sided heart failure. The pale periportal zones reflect normal or fatty liver tissue.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The liver derives its blood supply from the portal venous system and the hepatic artery. The portal triad constitutes:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Branches of the hepatic artery</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Portal vein</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bile duct</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The blood from the portal vein and the hepatic artery flow through the intervening sinusoids and drains into the central vein. The central veins from adjacent lobules form interlobular veins, which then unite as hepatic veins and finally drain into the inferior vena cava.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">The hepatic lobule is divided into three zones:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Zone 1 is the periportal area</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Zone 2 is the Intermediate zone</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Zone 3 is the area closest to the central vein</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Right-sided cardiac failure leads to passive congestion of the liver</span></strong><span style=\"font-size:12.0pt\">. Left-sided cardiac failure leads to hypoperfusion and hypoxia of hepatocytes around central veins. The combination of hypoperfusion and retrograde congestion causes centrilobular hemorrhagic necrosis, leading to this mottled appearance of the liver, known as nutmeg liver.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Dark areas represent viable liver tissue, white areas represent necrosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is incorrect because the dark areas are where necrosis has occurred due to congestion, not viable tissue.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. White areas represent central hepatocytes</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The white areas represent periportal zones, which are generally healthier and not central hepatocytes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Dark areas represent peri-portal hepatocytes</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The dark areas actually represent the centrilobular regions where necrosis has occurred, not the periportal hepatocytes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nutmeg liver&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is characterized by a mottled appearance, where <strong>dark areas represent necrosis</strong> due to chronic passive congestion, and <strong>white areas represent viable liver tissue</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: Robbins pathologic basis of disease 8<sup>th</sup> edition pg 1665</span></strong></span></span></p>",
    "correct_choice_id": 41938,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 9818,
    "choices": [
      {
        "id": 39239,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Promoter insertion</span></span></span></p>"
      },
      {
        "id": 39240,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Enhancer deletion</span></span></span></p>"
      },
      {
        "id": 39241,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gene amplification</span></span></span></p>"
      },
      {
        "id": 39242,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Point mutation</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The mutations/changes that convert proto-oncogene to oncogene include all except: (AIIMS NOV 2019)</span></span></p>",
    "unique_key": "Q3513678",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676655,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Enhancer deletion</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Enhancer deletion does not convert a proto-oncogene to an oncogene. </span><span style=\"font-size:12.0pt\">On the contrary, deletion of an enhancer would likely reduce the expression of the gene, potentially reducing its oncogenic potential, rather than increasing it.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Selected oncogenes, Their Mode of Activation, and Associated Human Tumors</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-104500_7dqf6dT.png\" style=\"height:961px; width:1000px\" /></p>\r\n\r\n<p style=\"margin-right:3px\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-180427.png\" style=\"height:287px; width:1000px\" /></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Promoter insertion</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Can convert a proto-oncogene to an oncogene by increasing gene transcription.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Gene amplification</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Leads to an increased number of gene copies, enhancing gene product levels, and contributing to oncogenesis.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D. Point mutation</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: A common mechanism for converting proto-oncogenes to oncogenes by altering the protein product to make it constitutively active.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Transformation of proto-oncogene (i.e., normal cell proliferation gene) to oncogenes (i.e., cancer cell proliferation gene) may occur by three mechanisms:</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:lower-roman\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Point mutations</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> i.e., an alteration of a single base in the DNA chain. Eg:- RAS oncogene carried in many human tumors such as bladder cancer, pancreatic adenocarcinoma, cholangiocarcinoma. Point mutations, deletions, or insertions in the promoter region of a proto-oncogene that led to increased transcription.&nbsp; </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chromosomal translocations</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> i.e., transfer of a portion of one chromosome carrying protooncogene to another chromosome and making it independent of growth controls.&nbsp; Eg :- Philadelphia chromosome seen in 95% cases of chronic myelogenous leukemia in which c-ABL protooncogene on chromosome 9 is translocated to chromosome 22.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gene amplification</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> i.e., increasing the number of copies of DNA sequence in protooncogene leading to increased mDNA and thus increased or overexpressed gene product. Eg:- Neuroblastoma having n-MYC HSR region,&nbsp; ERB-B1 in breast and ovarian cancer. </span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and Cotran Pathologic basis of disease, 8<sup>th</sup> edition, Pg no. 549-551</span></strong></span></span></p>",
    "correct_choice_id": 39240,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 32307,
    "choices": [
      {
        "id": 129086,
        "text": "<p><span style=\"font-size:12.0pt;\">Factor 8 deficiency</span></p>"
      },
      {
        "id": 129087,
        "text": "<p><span style=\"font-size:12.0pt;\">Factor 9 deficiency</span></p>"
      },
      {
        "id": 129088,
        "text": "<p><span style=\"font-size:12.0pt;\">Factor 11 deficiency</span></p>"
      },
      {
        "id": 129089,
        "text": "<p><span style=\"font-size:12.0pt;\">Von willebrand disease</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A male child presented with easy bruisability leading to detailed investigations which revealed normal PT, prolonged APTT and normal bleeding time. Which of the following cannot be cause of his condition? (FMGE JULY 2023)</span></p>",
    "unique_key": "Q7779289",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676633,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Von willebrand disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The combination of normal prothrombin time (PT), prolonged activated partial thromboplastin time (APTT), and normal bleeding time indicates a defect in the intrinsic pathway of the coagulation cascade, which includes factors VIII, IX, and XI.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Factor 8 deficiency&nbsp;</strong>(Hemophilia A), <strong>Factor 9 deficiency</strong> (Hemophilia B), and <strong>Factor 11 deficiency</strong> (Hemophilia C) all cause a prolonged APTT with normal PT and bleeding time.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Von Willebrand disease (vWD) affects both platelet function and the intrinsic pathway of coagulation, leading to an increased bleeding time and often a prolonged APTT. However, the presence of a normal bleeding time in this patient rules out vWD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Factor 8 deficiency</strong>: This would present with prolonged APTT and normal PT, consistent with the findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Factor 9 deficiency</strong>: This would also present with prolonged APTT and normal PT, consistent with the findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Factor 11 deficiency</strong>: This would similarly present with prolonged APTT and normal PT, consistent with the findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Isolated increased APTT can be caused by clotting factor deficiency of the intrinsic pathway like hemophilia A/B/C. von Willebrand disease is associated with increased bleeding time and increased APTT.</span></p>",
    "correct_choice_id": 129089,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE"
    ]
  }
];
        let quizName = 'Late Night Pyq:Pyt (Pathology-4)';
        let hierarchy = ["Cerebellum", "Mock Test", "Late Night PYQ"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        const urlParams = new URLSearchParams(window.location.search);
        currentQuestionIndex = Math.min(parseInt(urlParams.get('startAt')) || 0, questionsData.length - 1);

        function goBack() {
            if (isQuizCompleted || confirm('Are you sure you want to leave the quiz? Your progress will be lost.')) {
                window.history.back();
            }
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                setTimeout(processAnswer, 300);
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            setTimeout(showSolution, 1500);
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (!window.location.pathname.endsWith('custom_quiz.html')) {
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>